BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 835086 CO[C@H](C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2cccnn2)s1)c1cccc(c1)N1CC(F)C1 InChI=1S/C22H25FN8O2S/c1-33-19(14-4-2-5-17(10-14)31-11-15(23)12-31)20(32)26-22-29-28-21(34-22)25-16-7-9-30(13-16)18-6-3-8-24-27-18/h2-6,8,10,15-16,19H,7,9,11-13H2,1H3,(H,25,28)(H,26,29,32)/t16-,19+/m1/s1 ZDCKWVSAJLNKEB-APWZRJJASA-N 416638 (2S)-2-[3-(3-Fluoroazetidin-1-yl)phenyl]-2-methoxy-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide and (2R)-2-[3-(3-Fluoroazetidin-1-yl)phenyl]-2-methoxy-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide::US10323028, Example 1(a)::US10981904, Example 1(a) Glutaminase kidney isoform, mitochondrial Homo sapiens 20.6 US Patent 10.7270/Q20R9RTG aid1803901 US10323028 Nissink, JW; Finlay, MR; Charles, MD 6/18/2019 8/24/2020 AstraZeneca AB http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416638 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5879&target=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416638&enzyme=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search 129161505 433916564 1 MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL 3CZD,3UNW,3UO9,3VOY,3VOZ,3VP0,3VP1,3VP2,3VP3,3VP4,5FI2,5FI6,5FI7,5HL1,6LOX,6UL9,6UMD,7REN,7RGG,8BSK,8BSL,8BSM,8BSN,8GWR Glutaminase kidney isoform, mitochondrial GLSK_HUMAN O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40 835087 CO[C@@H](C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2cccnn2)s1)c1cccc(c1)N1CC(F)C1 InChI=1S/C22H25FN8O2S/c1-33-19(14-4-2-5-17(10-14)31-11-15(23)12-31)20(32)26-22-29-28-21(34-22)25-16-7-9-30(13-16)18-6-3-8-24-27-18/h2-6,8,10,15-16,19H,7,9,11-13H2,1H3,(H,25,28)(H,26,29,32)/t16-,19-/m1/s1 ZDCKWVSAJLNKEB-VQIMIIECSA-N 416639 (2R)-2-[3-(3-Fluoroazetidin-1-yl)phenyl]-2-methoxy-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide and (2R)-2-[3-(3-Fluoroazetidin-1-yl)phenyl]-2-methoxy-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide::US10323028, Example 1(b)::US10981904, Example 1(b) Glutaminase kidney isoform, mitochondrial Homo sapiens 72.6 US Patent 10.7270/Q20R9RTG aid1803901 US10323028 Nissink, JW; Finlay, MR; Charles, MD 6/18/2019 8/24/2020 AstraZeneca AB http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416639 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5879&target=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416639&enzyme=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search 129161516 433916565 1 MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL 3CZD,3UNW,3UO9,3VOY,3VOZ,3VP0,3VP1,3VP2,3VP3,3VP4,5FI2,5FI6,5FI7,5HL1,6LOX,6UL9,6UMD,7REN,7RGG,8BSK,8BSL,8BSM,8BSN,8GWR Glutaminase kidney isoform, mitochondrial GLSK_HUMAN O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40 835088 CO[C@H](C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2cccnn2)s1)c1cccc(c1)N1CC(F)(F)C1 InChI=1S/C22H24F2N8O2S/c1-34-18(14-4-2-5-16(10-14)32-12-22(23,24)13-32)19(33)27-21-30-29-20(35-21)26-15-7-9-31(11-15)17-6-3-8-25-28-17/h2-6,8,10,15,18H,7,9,11-13H2,1H3,(H,26,29)(H,27,30,33)/t15-,18+/m1/s1 IXAKTBDCLYIDBZ-QAPCUYQASA-N 416641 (2S)-2-[3-(3,3-Difluoroazetidin-1-yl)phenyl]-2-methoxy-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide and (2R)-2-[3-(3,3-Difluoroazetidin-1-yl)phenyl]-2-methoxy-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide::US10323028, Example 2(a)::US10981904, Example 2(a) Glutaminase kidney isoform, mitochondrial Homo sapiens 87.2 US Patent 10.7270/Q20R9RTG aid1803901 US10323028 Nissink, JW; Finlay, MR; Charles, MD 6/18/2019 8/24/2020 AstraZeneca AB http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416641 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5879&target=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416641&enzyme=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search 129161490 433916567 1 MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL 3CZD,3UNW,3UO9,3VOY,3VOZ,3VP0,3VP1,3VP2,3VP3,3VP4,5FI2,5FI6,5FI7,5HL1,6LOX,6UL9,6UMD,7REN,7RGG,8BSK,8BSL,8BSM,8BSN,8GWR Glutaminase kidney isoform, mitochondrial GLSK_HUMAN O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40 835089 CO[C@@H](C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2cccnn2)s1)c1cccc(c1)N1CC(F)(F)C1 InChI=1S/C22H24F2N8O2S/c1-34-18(14-4-2-5-16(10-14)32-12-22(23,24)13-32)19(33)27-21-30-29-20(35-21)26-15-7-9-31(11-15)17-6-3-8-25-28-17/h2-6,8,10,15,18H,7,9,11-13H2,1H3,(H,26,29)(H,27,30,33)/t15-,18-/m1/s1 IXAKTBDCLYIDBZ-CRAIPNDOSA-N 416642 (2R)-2-[3-(3,3-Difluoroazetidin-1-yl)phenyl]-2-methoxy-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide and (2R)-2-[3-(3,3-Difluoroazetidin-1-yl)phenyl]-2-methoxy-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide::US10323028, Example 2(b)::US10981904, Example 2(b) Glutaminase kidney isoform, mitochondrial Homo sapiens 121 US Patent 10.7270/Q20R9RTG aid1803901 US10323028 Nissink, JW; Finlay, MR; Charles, MD 6/18/2019 8/24/2020 AstraZeneca AB http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416642 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5879&target=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416642&enzyme=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search 129161469 433916568 1 MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL 3CZD,3UNW,3UO9,3VOY,3VOZ,3VP0,3VP1,3VP2,3VP3,3VP4,5FI2,5FI6,5FI7,5HL1,6LOX,6UL9,6UMD,7REN,7RGG,8BSK,8BSL,8BSM,8BSN,8GWR Glutaminase kidney isoform, mitochondrial GLSK_HUMAN O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40 835090 CO[C@H](C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2cccnn2)s1)c1cccc(c1)N1CC(C1)OC InChI=1S/C23H28N8O3S/c1-33-18-13-31(14-18)17-6-3-5-15(11-17)20(34-2)21(32)26-23-29-28-22(35-23)25-16-8-10-30(12-16)19-7-4-9-24-27-19/h3-7,9,11,16,18,20H,8,10,12-14H2,1-2H3,(H,25,28)(H,26,29,32)/t16-,20+/m1/s1 YNGDVDDWQYYAAN-UZLBHIALSA-N 416643 (2S)-2-Methoxy-2-[3-(3-methoxyazetidin-1-yl)phenyl]-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide and (2R)-2-Methoxy-2-[3-(3-methoxyazetidin-1-yl)phenyl]-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide::US10323028, Example 3(a)::US10981904, Example 3(a) Glutaminase kidney isoform, mitochondrial Homo sapiens 30.8 US Patent 10.7270/Q20R9RTG aid1803901 US10323028 Nissink, JW; Finlay, MR; Charles, MD 6/18/2019 8/24/2020 AstraZeneca AB http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416643 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5879&target=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416643&enzyme=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search 129161404 433916569 1 MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL 3CZD,3UNW,3UO9,3VOY,3VOZ,3VP0,3VP1,3VP2,3VP3,3VP4,5FI2,5FI6,5FI7,5HL1,6LOX,6UL9,6UMD,7REN,7RGG,8BSK,8BSL,8BSM,8BSN,8GWR Glutaminase kidney isoform, mitochondrial GLSK_HUMAN O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40 835091 CO[C@@H](C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2cccnn2)s1)c1cccc(c1)N1CC(C1)OC InChI=1S/C23H28N8O3S/c1-33-18-13-31(14-18)17-6-3-5-15(11-17)20(34-2)21(32)26-23-29-28-22(35-23)25-16-8-10-30(12-16)19-7-4-9-24-27-19/h3-7,9,11,16,18,20H,8,10,12-14H2,1-2H3,(H,25,28)(H,26,29,32)/t16-,20-/m1/s1 YNGDVDDWQYYAAN-OXQOHEQNSA-N 416644 (2R)-2-Methoxy-2-[3-(3-methoxyazetidin-1-yl)phenyl]-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide and (2R)-2-Methoxy-2-[3-(3-methoxyazetidin-1-yl)phenyl]-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide::US10323028, Example 3(b)::US10981904, Example 3(b) Glutaminase kidney isoform, mitochondrial Homo sapiens 72.1 US Patent 10.7270/Q20R9RTG aid1803901 US10323028 Nissink, JW; Finlay, MR; Charles, MD 6/18/2019 8/24/2020 AstraZeneca AB http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416644 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5879&target=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416644&enzyme=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search 129161466 433916570 1 MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL 3CZD,3UNW,3UO9,3VOY,3VOZ,3VP0,3VP1,3VP2,3VP3,3VP4,5FI2,5FI6,5FI7,5HL1,6LOX,6UL9,6UMD,7REN,7RGG,8BSK,8BSL,8BSM,8BSN,8GWR Glutaminase kidney isoform, mitochondrial GLSK_HUMAN O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40 835092 CO[C@H](C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2ccc(C)nn2)s1)c1cc(OC)cc(OC)c1 InChI=1S/C22H27N7O4S/c1-13-5-6-18(26-25-13)29-8-7-15(12-29)23-21-27-28-22(34-21)24-20(30)19(33-4)14-9-16(31-2)11-17(10-14)32-3/h5-6,9-11,15,19H,7-8,12H2,1-4H3,(H,23,27)(H,24,28,30)/t15-,19+/m1/s1 YISJONSTNPDOGI-BEFAXECRSA-N 416650 (2S)-2-(3,5-Dimethoxyphenyl)-2-methoxy-N-[5-[[(3R)-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide and (2R)-2-(3,5-Dimethoxyphenyl)-2-methoxy-N-[5-[[(3R)-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide::US10323028, Example 4(a)::US10981904, Example 4(a) Glutaminase kidney isoform, mitochondrial Homo sapiens 42.3 US Patent 10.7270/Q20R9RTG aid1803901 US10323028 Nissink, JW; Finlay, MR; Charles, MD 6/18/2019 8/24/2020 AstraZeneca AB http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416650 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5879&target=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416650&enzyme=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search 129161498 433916576 1 MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL 3CZD,3UNW,3UO9,3VOY,3VOZ,3VP0,3VP1,3VP2,3VP3,3VP4,5FI2,5FI6,5FI7,5HL1,6LOX,6UL9,6UMD,7REN,7RGG,8BSK,8BSL,8BSM,8BSN,8GWR Glutaminase kidney isoform, mitochondrial GLSK_HUMAN O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40 835093 CO[C@@H](C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2ccc(C)nn2)s1)c1cc(OC)cc(OC)c1 InChI=1S/C22H27N7O4S/c1-13-5-6-18(26-25-13)29-8-7-15(12-29)23-21-27-28-22(34-21)24-20(30)19(33-4)14-9-16(31-2)11-17(10-14)32-3/h5-6,9-11,15,19H,7-8,12H2,1-4H3,(H,23,27)(H,24,28,30)/t15-,19-/m1/s1 YISJONSTNPDOGI-DNVCBOLYSA-N 416651 (2R)-2-(3,5-Dimethoxyphenyl)-2-methoxy-N-[5-[[(3R)-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide and (2R)-2-(3,5-Dimethoxyphenyl)-2-methoxy-N-[5-[[(3R)-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide::US10323028, Example 4(b)::US10981904, Example 4(b) Glutaminase kidney isoform, mitochondrial Homo sapiens 59.6 US Patent 10.7270/Q20R9RTG aid1803901 US10323028 Nissink, JW; Finlay, MR; Charles, MD 6/18/2019 8/24/2020 AstraZeneca AB http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416651 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5879&target=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416651&enzyme=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search 129161493 433916577 1 MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL 3CZD,3UNW,3UO9,3VOY,3VOZ,3VP0,3VP1,3VP2,3VP3,3VP4,5FI2,5FI6,5FI7,5HL1,6LOX,6UL9,6UMD,7REN,7RGG,8BSK,8BSL,8BSM,8BSN,8GWR Glutaminase kidney isoform, mitochondrial GLSK_HUMAN O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40 835094 COC[C@H](C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2cccnn2)s1)c1cccc(OC)c1 InChI=1S/C21H25N7O3S/c1-30-13-17(14-5-3-6-16(11-14)31-2)19(29)24-21-27-26-20(32-21)23-15-8-10-28(12-15)18-7-4-9-22-25-18/h3-7,9,11,15,17H,8,10,12-13H2,1-2H3,(H,23,26)(H,24,27,29)/t15-,17+/m1/s1 SQQHQXXXLATMLV-WBVHZDCISA-N 416652 (2R)-3-Methoxy-2-(3-methoxyphenyl)-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]propanamide and (2S)-3-Methoxy-2-(3-methoxyphenyl)-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]propanamide::US10323028, Example 5(a)::US10981904, Example 5(a) Glutaminase kidney isoform, mitochondrial Homo sapiens 28.8 US Patent 10.7270/Q20R9RTG aid1803901 US10323028 Nissink, JW; Finlay, MR; Charles, MD 6/18/2019 8/24/2020 AstraZeneca AB http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416652 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5879&target=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416652&enzyme=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search 129161478 433916578 1 MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL 3CZD,3UNW,3UO9,3VOY,3VOZ,3VP0,3VP1,3VP2,3VP3,3VP4,5FI2,5FI6,5FI7,5HL1,6LOX,6UL9,6UMD,7REN,7RGG,8BSK,8BSL,8BSM,8BSN,8GWR Glutaminase kidney isoform, mitochondrial GLSK_HUMAN O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40 835095 COC[C@@H](C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2cccnn2)s1)c1cccc(OC)c1 InChI=1S/C21H25N7O3S/c1-30-13-17(14-5-3-6-16(11-14)31-2)19(29)24-21-27-26-20(32-21)23-15-8-10-28(12-15)18-7-4-9-22-25-18/h3-7,9,11,15,17H,8,10,12-13H2,1-2H3,(H,23,26)(H,24,27,29)/t15-,17-/m1/s1 SQQHQXXXLATMLV-NVXWUHKLSA-N 416653 (2R)-3-Methoxy-2-(3-methoxyphenyl)-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]propanamide and (2S)-3-Methoxy-2-(3-methoxyphenyl)-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]propanamide::US10323028, Example 5(b)::US10981904, Example 5(b) Glutaminase kidney isoform, mitochondrial Homo sapiens 130 US Patent 10.7270/Q20R9RTG aid1803901 US10323028 Nissink, JW; Finlay, MR; Charles, MD 6/18/2019 8/24/2020 AstraZeneca AB http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416653 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5879&target=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416653&enzyme=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search 129161491 433916579 1 MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL 3CZD,3UNW,3UO9,3VOY,3VOZ,3VP0,3VP1,3VP2,3VP3,3VP4,5FI2,5FI6,5FI7,5HL1,6LOX,6UL9,6UMD,7REN,7RGG,8BSK,8BSL,8BSM,8BSN,8GWR Glutaminase kidney isoform, mitochondrial GLSK_HUMAN O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40 835096 CCO[C@H](C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2cccnn2)s1)c1cc(OC)cc(OC)c1 InChI=1S/C22H27N7O4S/c1-4-33-19(14-10-16(31-2)12-17(11-14)32-3)20(30)25-22-28-27-21(34-22)24-15-7-9-29(13-15)18-6-5-8-23-26-18/h5-6,8,10-12,15,19H,4,7,9,13H2,1-3H3,(H,24,27)(H,25,28,30)/t15-,19+/m1/s1 ASGBEFFYGLHCBE-BEFAXECRSA-N 416654 (2S)-2-(3,5-Dimethoxyphenyl)-2-ethoxy-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide and (2R)-2-(3,5-Dimethoxyphenyl)-2-ethoxy-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide::US10323028, Example 6(a)::US10981904, Example 6(a) Glutaminase kidney isoform, mitochondrial Homo sapiens 28.0 US Patent 10.7270/Q20R9RTG aid1803901 US10323028 Nissink, JW; Finlay, MR; Charles, MD 6/18/2019 8/24/2020 AstraZeneca AB http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416654 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5879&target=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416654&enzyme=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search 129161457 433916580 1 MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL 3CZD,3UNW,3UO9,3VOY,3VOZ,3VP0,3VP1,3VP2,3VP3,3VP4,5FI2,5FI6,5FI7,5HL1,6LOX,6UL9,6UMD,7REN,7RGG,8BSK,8BSL,8BSM,8BSN,8GWR Glutaminase kidney isoform, mitochondrial GLSK_HUMAN O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40 835097 CCO[C@@H](C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2cccnn2)s1)c1cc(OC)cc(OC)c1 InChI=1S/C22H27N7O4S/c1-4-33-19(14-10-16(31-2)12-17(11-14)32-3)20(30)25-22-28-27-21(34-22)24-15-7-9-29(13-15)18-6-5-8-23-26-18/h5-6,8,10-12,15,19H,4,7,9,13H2,1-3H3,(H,24,27)(H,25,28,30)/t15-,19-/m1/s1 ASGBEFFYGLHCBE-DNVCBOLYSA-N 416655 (2R)-2-(3,5-Dimethoxyphenyl)-2-ethoxy-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide and (2R)-2-(3,5-Dimethoxyphenyl)-2-ethoxy-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide::US10323028, Example 6(b)::US10981904, Example 6(b) Glutaminase kidney isoform, mitochondrial Homo sapiens 213 US Patent 10.7270/Q20R9RTG aid1803901 US10323028 Nissink, JW; Finlay, MR; Charles, MD 6/18/2019 8/24/2020 AstraZeneca AB http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416655 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5879&target=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416655&enzyme=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search 129161450 433916581 1 MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL 3CZD,3UNW,3UO9,3VOY,3VOZ,3VP0,3VP1,3VP2,3VP3,3VP4,5FI2,5FI6,5FI7,5HL1,6LOX,6UL9,6UMD,7REN,7RGG,8BSK,8BSL,8BSM,8BSN,8GWR Glutaminase kidney isoform, mitochondrial GLSK_HUMAN O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40 835098 CO[C@@H](C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2cccnn2)s1)c1ccc(F)c(c1)N1CC(C1)OC InChI=1S/C23H27FN8O3S/c1-34-16-12-32(13-16)18-10-14(5-6-17(18)24)20(35-2)21(33)27-23-30-29-22(36-23)26-15-7-9-31(11-15)19-4-3-8-25-28-19/h3-6,8,10,15-16,20H,7,9,11-13H2,1-2H3,(H,26,29)(H,27,30,33)/t15-,20-/m1/s1 UMJHPBFCPYNKTO-FOIQADDNSA-N 416656 (2R)-2-[4-Fluoro-3-(3-methoxyazetidin-1-yl)phenyl]-2-methoxy-N-[5-[(3R)-3-(pyridazin-3-ylamino)pyrrolidin-1-yl]-1,3,4-thiadiazol-2-yl]acetamide and (2R)-2-[4-Fluoro-3-(3-methoxyazetidin-1-yl)phenyl]-2-methoxy-N-[5-[(3R)-3-(pyridazin-3-ylamino)pyrrolidin-1-yl]-1,3,4-thiadiazol-2-yl]acetamide::US10323028, Example 7(b) Glutaminase kidney isoform, mitochondrial Homo sapiens 192 US Patent 10.7270/Q20R9RTG aid1803901 US10323028 Nissink, JW; Finlay, MR; Charles, MD 6/18/2019 8/24/2020 AstraZeneca AB http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416656 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5879&target=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416656&enzyme=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search 129182239 433916582 1 MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL 3CZD,3UNW,3UO9,3VOY,3VOZ,3VP0,3VP1,3VP2,3VP3,3VP4,5FI2,5FI6,5FI7,5HL1,6LOX,6UL9,6UMD,7REN,7RGG,8BSK,8BSL,8BSM,8BSN,8GWR Glutaminase kidney isoform, mitochondrial GLSK_HUMAN O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40 835099 CO[C@H](C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2cccnn2)s1)c1ccc(F)c(c1)N1CC(F)C1 InChI=1S/C22H24F2N8O2S/c1-34-19(13-4-5-16(24)17(9-13)32-10-14(23)11-32)20(33)27-22-30-29-21(35-22)26-15-6-8-31(12-15)18-3-2-7-25-28-18/h2-5,7,9,14-15,19H,6,8,10-12H2,1H3,(H,26,29)(H,27,30,33)/t15-,19+/m1/s1 SIFSZFVWICOXGZ-BEFAXECRSA-N 416657 (2S)-2-[4-Fluoro-3-(3-fluoroazetidin-1-yl)phenyl]-2-methoxy-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide and (2R)-2-[4-Fluoro-3-(3-fluoroazetidin-1-yl)phenyl]-2-methoxy-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide::US10323028, Example 8(a)::US10981904, Example 8(a) Glutaminase kidney isoform, mitochondrial Homo sapiens 64.9 US Patent 10.7270/Q20R9RTG aid1803901 US10323028 Nissink, JW; Finlay, MR; Charles, MD 6/18/2019 8/24/2020 AstraZeneca AB http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416657 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5879&target=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416657&enzyme=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search 129161451 433916583 1 MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL 3CZD,3UNW,3UO9,3VOY,3VOZ,3VP0,3VP1,3VP2,3VP3,3VP4,5FI2,5FI6,5FI7,5HL1,6LOX,6UL9,6UMD,7REN,7RGG,8BSK,8BSL,8BSM,8BSN,8GWR Glutaminase kidney isoform, mitochondrial GLSK_HUMAN O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40 835100 CO[C@@H](C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2cccnn2)s1)c1ccc(F)c(c1)N1CC(F)C1 InChI=1S/C22H24F2N8O2S/c1-34-19(13-4-5-16(24)17(9-13)32-10-14(23)11-32)20(33)27-22-30-29-21(35-22)26-15-6-8-31(12-15)18-3-2-7-25-28-18/h2-5,7,9,14-15,19H,6,8,10-12H2,1H3,(H,26,29)(H,27,30,33)/t15-,19-/m1/s1 SIFSZFVWICOXGZ-DNVCBOLYSA-N 416658 (2R)-2-[4-Fluoro-3-(3-fluoroazetidin-1-yl)phenyl]-2-methoxy-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide and (2R)-2-[4-Fluoro-3-(3-fluoroazetidin-1-yl)phenyl]-2-methoxy-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide::US10323028, Example 8(b)::US10981904, Example 8(b) Glutaminase kidney isoform, mitochondrial Homo sapiens 190 US Patent 10.7270/Q20R9RTG aid1803901 US10323028 Nissink, JW; Finlay, MR; Charles, MD 6/18/2019 8/24/2020 AstraZeneca AB http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416658 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5879&target=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416658&enzyme=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search 129161511 433916584 1 MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL 3CZD,3UNW,3UO9,3VOY,3VOZ,3VP0,3VP1,3VP2,3VP3,3VP4,5FI2,5FI6,5FI7,5HL1,6LOX,6UL9,6UMD,7REN,7RGG,8BSK,8BSL,8BSM,8BSN,8GWR Glutaminase kidney isoform, mitochondrial GLSK_HUMAN O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40 835101 CO[C@H](C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2ccc(F)nn2)s1)c1cccc(c1)N1CC(C1)OC InChI=1S/C23H27FN8O3S/c1-34-17-12-32(13-17)16-5-3-4-14(10-16)20(35-2)21(33)26-23-30-29-22(36-23)25-15-8-9-31(11-15)19-7-6-18(24)27-28-19/h3-7,10,15,17,20H,8-9,11-13H2,1-2H3,(H,25,29)(H,26,30,33)/t15-,20+/m1/s1 BVXKPJNFBXKDMN-QRWLVFNGSA-N 416661 (2S)-N-[5-[[(3R)-1-(6-Fluoropyridazin-3-yl)pyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]-2-methoxy-2-[3-(3-methoxyazetidin-1-yl)phenyl]acetamide and (2R)—N-[5-[[(3R)-1-(6-Fluoropyridazin-3-yl)pyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]-2-methoxy-2-[3-(3-methoxyazetidin-1-yl)phenyl]acetamide::US10323028, Example 9(a)::US10981904, Example 9(b) Glutaminase kidney isoform, mitochondrial Homo sapiens 59.1 US Patent 10.7270/Q20R9RTG aid1803901 US10323028 Nissink, JW; Finlay, MR; Charles, MD 6/18/2019 8/24/2020 AstraZeneca AB http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416661 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5879&target=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416661&enzyme=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search 129161416 433916587 1 MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL 3CZD,3UNW,3UO9,3VOY,3VOZ,3VP0,3VP1,3VP2,3VP3,3VP4,5FI2,5FI6,5FI7,5HL1,6LOX,6UL9,6UMD,7REN,7RGG,8BSK,8BSL,8BSM,8BSN,8GWR Glutaminase kidney isoform, mitochondrial GLSK_HUMAN O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40 835102 CO[C@@H](C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2ccc(F)nn2)s1)c1cccc(c1)N1CC(C1)OC InChI=1S/C23H27FN8O3S/c1-34-17-12-32(13-17)16-5-3-4-14(10-16)20(35-2)21(33)26-23-30-29-22(36-23)25-15-8-9-31(11-15)19-7-6-18(24)27-28-19/h3-7,10,15,17,20H,8-9,11-13H2,1-2H3,(H,25,29)(H,26,30,33)/t15-,20-/m1/s1 BVXKPJNFBXKDMN-FOIQADDNSA-N 416663 (2R)-N-[5-[[(3R)-1-(6-Fluoropyridazin-3-yl)pyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]-2-methoxy-2-[3-(3-methoxyazetidin-1-yl)phenyl]acetamide and (2R)—N-[5-[[(3R)-1-(6-Fluoropyridazin-3-yl)pyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]-2-methoxy-2-[3-(3-methoxyazetidin-1-yl)phenyl]acetamide::US10323028, Example 9(b)::US10981904, Example 9(a) Glutaminase kidney isoform, mitochondrial Homo sapiens 519 US Patent 10.7270/Q20R9RTG aid1803901 US10323028 Nissink, JW; Finlay, MR; Charles, MD 6/18/2019 8/24/2020 AstraZeneca AB http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416663 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5879&target=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416663&enzyme=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search 129161438 433916589 1 MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL 3CZD,3UNW,3UO9,3VOY,3VOZ,3VP0,3VP1,3VP2,3VP3,3VP4,5FI2,5FI6,5FI7,5HL1,6LOX,6UL9,6UMD,7REN,7RGG,8BSK,8BSL,8BSM,8BSN,8GWR Glutaminase kidney isoform, mitochondrial GLSK_HUMAN O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40 835103 CO[C@@H](C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2cccnn2)s1)c1cc(OC)cc(c1)N1CC(F)C1 InChI=1S/C23H27FN8O3S/c1-34-18-9-14(8-17(10-18)32-11-15(24)12-32)20(35-2)21(33)27-23-30-29-22(36-23)26-16-5-7-31(13-16)19-4-3-6-25-28-19/h3-4,6,8-10,15-16,20H,5,7,11-13H2,1-2H3,(H,26,29)(H,27,30,33)/t16-,20-/m1/s1 ZHRNCBVUEKDLAI-OXQOHEQNSA-N 416664 (2S)-2-[3-(3-Fluoroazetidin-1-yl)-5-methoxy-phenyl]-2-methoxy-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide and (2R)-2-[3-(3-Fluoroazetidin-1-yl)-5-methoxy-phenyl]-2-methoxy-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide::US10323028, Example 10(a)::US10323028, Example 10(b)::US10981904, Example 10(a) Glutaminase kidney isoform, mitochondrial Homo sapiens 34.9 US Patent 10.7270/Q20R9RTG aid1803901 US10323028 Nissink, JW; Finlay, MR; Charles, MD 6/18/2019 8/24/2020 AstraZeneca AB http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416664 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5879&target=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416664&enzyme=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search 129161468 433916590 1 MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL 3CZD,3UNW,3UO9,3VOY,3VOZ,3VP0,3VP1,3VP2,3VP3,3VP4,5FI2,5FI6,5FI7,5HL1,6LOX,6UL9,6UMD,7REN,7RGG,8BSK,8BSL,8BSM,8BSN,8GWR Glutaminase kidney isoform, mitochondrial GLSK_HUMAN O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40 835104 CO[C@@H](C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2cccnn2)s1)c1cc(OC)cc(c1)N1CC(F)C1 InChI=1S/C23H27FN8O3S/c1-34-18-9-14(8-17(10-18)32-11-15(24)12-32)20(35-2)21(33)27-23-30-29-22(36-23)26-16-5-7-31(13-16)19-4-3-6-25-28-19/h3-4,6,8-10,15-16,20H,5,7,11-13H2,1-2H3,(H,26,29)(H,27,30,33)/t16-,20-/m1/s1 ZHRNCBVUEKDLAI-OXQOHEQNSA-N 416664 (2S)-2-[3-(3-Fluoroazetidin-1-yl)-5-methoxy-phenyl]-2-methoxy-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide and (2R)-2-[3-(3-Fluoroazetidin-1-yl)-5-methoxy-phenyl]-2-methoxy-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide::US10323028, Example 10(a)::US10323028, Example 10(b)::US10981904, Example 10(a) Glutaminase kidney isoform, mitochondrial Homo sapiens 72.2 US Patent 10.7270/Q20R9RTG aid1803901 US10323028 Nissink, JW; Finlay, MR; Charles, MD 6/18/2019 8/24/2020 AstraZeneca AB http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416664 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5879&target=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416664&enzyme=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search 129161468 433916590 1 MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL 3CZD,3UNW,3UO9,3VOY,3VOZ,3VP0,3VP1,3VP2,3VP3,3VP4,5FI2,5FI6,5FI7,5HL1,6LOX,6UL9,6UMD,7REN,7RGG,8BSK,8BSL,8BSM,8BSN,8GWR Glutaminase kidney isoform, mitochondrial GLSK_HUMAN O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40 835105 CO[C@H](C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2cccnn2)s1)c1cc(OC)cc(OC(F)(F)F)c1 InChI=1S/C21H22F3N7O4S/c1-33-14-8-12(9-15(10-14)35-21(22,23)24)17(34-2)18(32)27-20-30-29-19(36-20)26-13-5-7-31(11-13)16-4-3-6-25-28-16/h3-4,6,8-10,13,17H,5,7,11H2,1-2H3,(H,26,29)(H,27,30,32)/t13-,17+/m1/s1 ZFCXIZUETUNJKI-DYVFJYSZSA-N 416666 (2S)-2-Methoxy-2-[3-methoxy-5-(trifluoromethoxy)phenyl]-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide and (2R)-2-methoxy-2-[3-methoxy-5-(trifluoromethoxy)phenyl]-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide::US10323028, Example 11(a)::US10981904, Example 11(b) Glutaminase kidney isoform, mitochondrial Homo sapiens 6.35 US Patent 10.7270/Q20R9RTG aid1803901 US10323028 Nissink, JW; Finlay, MR; Charles, MD 6/18/2019 8/24/2020 AstraZeneca AB http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416666 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5879&target=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416666&enzyme=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search 129161488 433916591 1 MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL 3CZD,3UNW,3UO9,3VOY,3VOZ,3VP0,3VP1,3VP2,3VP3,3VP4,5FI2,5FI6,5FI7,5HL1,6LOX,6UL9,6UMD,7REN,7RGG,8BSK,8BSL,8BSM,8BSN,8GWR Glutaminase kidney isoform, mitochondrial GLSK_HUMAN O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40 835106 CO[C@@H](C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2cccnn2)s1)c1cc(OC)cc(OC(F)(F)F)c1 InChI=1S/C21H22F3N7O4S/c1-33-14-8-12(9-15(10-14)35-21(22,23)24)17(34-2)18(32)27-20-30-29-19(36-20)26-13-5-7-31(11-13)16-4-3-6-25-28-16/h3-4,6,8-10,13,17H,5,7,11H2,1-2H3,(H,26,29)(H,27,30,32)/t13-,17-/m1/s1 ZFCXIZUETUNJKI-CXAGYDPISA-N 416667 (2R)-2-Methoxy-2-[3-methoxy-5-(trifluoromethoxy)phenyl]-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide and (2R)-2-methoxy-2-[3-methoxy-5-(trifluoromethoxy)phenyl]-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide::US10323028, Example 11(b)::US10981904, Example 11(a) Glutaminase kidney isoform, mitochondrial Homo sapiens 6.11 US Patent 10.7270/Q20R9RTG aid1803901 US10323028 Nissink, JW; Finlay, MR; Charles, MD 6/18/2019 8/24/2020 AstraZeneca AB http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416667 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5879&target=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416667&enzyme=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search 129161398 433916592 1 MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL 3CZD,3UNW,3UO9,3VOY,3VOZ,3VP0,3VP1,3VP2,3VP3,3VP4,5FI2,5FI6,5FI7,5HL1,6LOX,6UL9,6UMD,7REN,7RGG,8BSK,8BSL,8BSM,8BSN,8GWR Glutaminase kidney isoform, mitochondrial GLSK_HUMAN O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40 835107 CO[C@H](C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2ccc(C)nn2)s1)c1cccc(c1)N1CC(C1)OC InChI=1S/C24H30N8O3S/c1-15-7-8-20(28-27-15)31-10-9-17(12-31)25-23-29-30-24(36-23)26-22(33)21(35-3)16-5-4-6-18(11-16)32-13-19(14-32)34-2/h4-8,11,17,19,21H,9-10,12-14H2,1-3H3,(H,25,29)(H,26,30,33)/t17-,21+/m1/s1 SMLCGOSBZPGHOV-UTKZUKDTSA-N 416668 (2S)-2-Methoxy-2-[3-(3-methoxyazetidin-1-yl)phenyl]-N-[5-[[(3R)-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide and (2R)-2-Methoxy-2-[3-(3-methoxyazetidin-1-yl)phenyl]-N-[5-[[(3R)-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide::US10323028, Example 12(a)::US10981904, Example 12(b) Glutaminase kidney isoform, mitochondrial Homo sapiens 43.8 US Patent 10.7270/Q20R9RTG aid1803901 US10323028 Nissink, JW; Finlay, MR; Charles, MD 6/18/2019 8/24/2020 AstraZeneca AB http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416668 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5879&target=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416668&enzyme=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search 129161423 433916593 1 MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL 3CZD,3UNW,3UO9,3VOY,3VOZ,3VP0,3VP1,3VP2,3VP3,3VP4,5FI2,5FI6,5FI7,5HL1,6LOX,6UL9,6UMD,7REN,7RGG,8BSK,8BSL,8BSM,8BSN,8GWR Glutaminase kidney isoform, mitochondrial GLSK_HUMAN O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40 835108 CO[C@@H](C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2ccc(C)nn2)s1)c1cccc(c1)N1CC(C1)OC InChI=1S/C24H30N8O3S/c1-15-7-8-20(28-27-15)31-10-9-17(12-31)25-23-29-30-24(36-23)26-22(33)21(35-3)16-5-4-6-18(11-16)32-13-19(14-32)34-2/h4-8,11,17,19,21H,9-10,12-14H2,1-3H3,(H,25,29)(H,26,30,33)/t17-,21-/m1/s1 SMLCGOSBZPGHOV-DYESRHJHSA-N 416669 (2R)-2-Methoxy-2-[3-(3-methoxyazetidin-1-yl)phenyl]-N-[5-[[(3R)-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide and (2R)-2-Methoxy-2-[3-(3-methoxyazetidin-1-yl)phenyl]-N-[5-[[(3R)-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide::US10323028, Example 12(b)::US10981904, Example 12(a) Glutaminase kidney isoform, mitochondrial Homo sapiens 971 US Patent 10.7270/Q20R9RTG aid1803901 US10323028 Nissink, JW; Finlay, MR; Charles, MD 6/18/2019 8/24/2020 AstraZeneca AB http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416669 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5879&target=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416669&enzyme=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search 129161507 433916594 1 MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL 3CZD,3UNW,3UO9,3VOY,3VOZ,3VP0,3VP1,3VP2,3VP3,3VP4,5FI2,5FI6,5FI7,5HL1,6LOX,6UL9,6UMD,7REN,7RGG,8BSK,8BSL,8BSM,8BSN,8GWR Glutaminase kidney isoform, mitochondrial GLSK_HUMAN O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40 835109 CO[C@H](C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2nccnn2)s1)c1cccc(c1)N1CC(C1)OC InChI=1S/C22H27N9O3S/c1-33-17-12-31(13-17)16-5-3-4-14(10-16)18(34-2)19(32)26-22-29-28-21(35-22)25-15-6-9-30(11-15)20-23-7-8-24-27-20/h3-5,7-8,10,15,17-18H,6,9,11-13H2,1-2H3,(H,25,28)(H,26,29,32)/t15-,18+/m1/s1 JAXWZAXQAUTYLQ-QAPCUYQASA-N 416670 (2S)-2-Methoxy-2-[3-(3-methoxyazetidin-1-yl)phenyl]-N-[5-[[(3R)-1-(1,2,4-triazin-3-yl)pyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide and (2R)-2-Methoxy-2-[3-(3-methoxyazetidin-1-yl)phenyl]-N-[5-[[(3R)-1-(1,2,4-triazin-3-yl)pyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide::US10323028, Example 13(a)::US10981904, Example 13(b) Glutaminase kidney isoform, mitochondrial Homo sapiens 75.1 US Patent 10.7270/Q20R9RTG aid1803901 US10323028 Nissink, JW; Finlay, MR; Charles, MD 6/18/2019 8/24/2020 AstraZeneca AB http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416670 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5879&target=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416670&enzyme=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search 129161452 433916595 1 MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL 3CZD,3UNW,3UO9,3VOY,3VOZ,3VP0,3VP1,3VP2,3VP3,3VP4,5FI2,5FI6,5FI7,5HL1,6LOX,6UL9,6UMD,7REN,7RGG,8BSK,8BSL,8BSM,8BSN,8GWR Glutaminase kidney isoform, mitochondrial GLSK_HUMAN O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40 835110 CO[C@@H](C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2nccnn2)s1)c1cccc(c1)N1CC(C1)OC InChI=1S/C22H27N9O3S/c1-33-17-12-31(13-17)16-5-3-4-14(10-16)18(34-2)19(32)26-22-29-28-21(35-22)25-15-6-9-30(11-15)20-23-7-8-24-27-20/h3-5,7-8,10,15,17-18H,6,9,11-13H2,1-2H3,(H,25,28)(H,26,29,32)/t15-,18-/m1/s1 JAXWZAXQAUTYLQ-CRAIPNDOSA-N 416671 (2R)-2-Methoxy-2-[3-(3-methoxyazetidin-1-yl)phenyl]-N-[5-[[(3R)-1-(1,2,4-triazin-3-yl)pyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide and (2R)-2-Methoxy-2-[3-(3-methoxyazetidin-1-yl)phenyl]-N-[5-[[(3R)-1-(1,2,4-triazin-3-yl)pyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide::US10323028, Example 13(b)::US10981904, Example 13(a) Glutaminase kidney isoform, mitochondrial Homo sapiens 1420 US Patent 10.7270/Q20R9RTG aid1803901 US10323028 Nissink, JW; Finlay, MR; Charles, MD 6/18/2019 8/24/2020 AstraZeneca AB http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416671 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5879&target=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416671&enzyme=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search 129161463 433916596 1 MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL 3CZD,3UNW,3UO9,3VOY,3VOZ,3VP0,3VP1,3VP2,3VP3,3VP4,5FI2,5FI6,5FI7,5HL1,6LOX,6UL9,6UMD,7REN,7RGG,8BSK,8BSL,8BSM,8BSN,8GWR Glutaminase kidney isoform, mitochondrial GLSK_HUMAN O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40 835111 CO[C@H](C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2nccnn2)s1)c1cccc(c1)N1CC(F)(F)C1 InChI=1S/C21H23F2N9O2S/c1-34-16(13-3-2-4-15(9-13)32-11-21(22,23)12-32)17(33)27-20-30-29-19(35-20)26-14-5-8-31(10-14)18-24-6-7-25-28-18/h2-4,6-7,9,14,16H,5,8,10-12H2,1H3,(H,26,29)(H,27,30,33)/t14-,16+/m1/s1 DXYFFQSFEMTYKX-ZBFHGGJFSA-N 416672 (2S)-2-[3-(3,3-Difluoroazetidin-1-yl)phenyl]-2-methoxy-N-[5-[[(3R)-1-(1,2,4-triazin-3-yl)pyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide and (2R)-2-[3-(3,3-Difluoroazetidin-1-yl)phenyl]-2-methoxy-N-[5-[[(3R)-1-(1,2,4-triazin-3-yl)pyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide::US10323028, Example 14(a)::US10981904, Example 14(b) Glutaminase kidney isoform, mitochondrial Homo sapiens 91.5 US Patent 10.7270/Q20R9RTG aid1803901 US10323028 Nissink, JW; Finlay, MR; Charles, MD 6/18/2019 8/24/2020 AstraZeneca AB http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416672 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5879&target=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416672&enzyme=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search 129161444 433916597 1 MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL 3CZD,3UNW,3UO9,3VOY,3VOZ,3VP0,3VP1,3VP2,3VP3,3VP4,5FI2,5FI6,5FI7,5HL1,6LOX,6UL9,6UMD,7REN,7RGG,8BSK,8BSL,8BSM,8BSN,8GWR Glutaminase kidney isoform, mitochondrial GLSK_HUMAN O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40 835112 CO[C@@H](C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2nccnn2)s1)c1cccc(c1)N1CC(F)(F)C1 InChI=1S/C21H23F2N9O2S/c1-34-16(13-3-2-4-15(9-13)32-11-21(22,23)12-32)17(33)27-20-30-29-19(35-20)26-14-5-8-31(10-14)18-24-6-7-25-28-18/h2-4,6-7,9,14,16H,5,8,10-12H2,1H3,(H,26,29)(H,27,30,33)/t14-,16-/m1/s1 DXYFFQSFEMTYKX-GDBMZVCRSA-N 416673 (2R)-2-[3-(3,3-Difluoroazetidin-1-yl)phenyl]-2-methoxy-N-[5-[[(3R)-1-(1,2,4-triazin-3-yl)pyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide and (2R)-2-[3-(3,3-Difluoroazetidin-1-yl)phenyl]-2-methoxy-N-[5-[[(3R)-1-(1,2,4-triazin-3-yl)pyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide::US10323028, Example 14(b)::US10981904, Example 14(a) Glutaminase kidney isoform, mitochondrial Homo sapiens 660 US Patent 10.7270/Q20R9RTG aid1803901 US10323028 Nissink, JW; Finlay, MR; Charles, MD 6/18/2019 8/24/2020 AstraZeneca AB http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416673 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5879&target=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416673&enzyme=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search 129161462 433916598 1 MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL 3CZD,3UNW,3UO9,3VOY,3VOZ,3VP0,3VP1,3VP2,3VP3,3VP4,5FI2,5FI6,5FI7,5HL1,6LOX,6UL9,6UMD,7REN,7RGG,8BSK,8BSL,8BSM,8BSN,8GWR Glutaminase kidney isoform, mitochondrial GLSK_HUMAN O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40 835113 CO[C@H](C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2nccnn2)s1)c1cccc(c1)N1CC(F)C1 InChI=1S/C21H24FN9O2S/c1-33-17(13-3-2-4-16(9-13)31-10-14(22)11-31)18(32)26-21-29-28-20(34-21)25-15-5-8-30(12-15)19-23-6-7-24-27-19/h2-4,6-7,9,14-15,17H,5,8,10-12H2,1H3,(H,25,28)(H,26,29,32)/t15-,17+/m1/s1 NSGZZBXIXXUHJV-WBVHZDCISA-N 416674 (2S)-2-[3-(3-Fluoroazetidin-1-yl)phenyl]-2-methoxy-N-[5-[[(3R)-1-(1,2,4-triazin-3-yl)pyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide and (2R)-2-[3-(3-Fluoroazetidin-1-yl)phenyl]-2-methoxy-N-[5-[[(3R)-1-(1,2,4-triazin-3-yl)pyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide::US10323028, Example 15(a)::US10981904, Example 15(b) Glutaminase kidney isoform, mitochondrial Homo sapiens 77.6 US Patent 10.7270/Q20R9RTG aid1803901 US10323028 Nissink, JW; Finlay, MR; Charles, MD 6/18/2019 8/24/2020 AstraZeneca AB http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416674 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5879&target=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416674&enzyme=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search 129161431 433916599 1 MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL 3CZD,3UNW,3UO9,3VOY,3VOZ,3VP0,3VP1,3VP2,3VP3,3VP4,5FI2,5FI6,5FI7,5HL1,6LOX,6UL9,6UMD,7REN,7RGG,8BSK,8BSL,8BSM,8BSN,8GWR Glutaminase kidney isoform, mitochondrial GLSK_HUMAN O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40 835114 CO[C@@H](C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2nccnn2)s1)c1cccc(c1)N1CC(F)C1 InChI=1S/C21H24FN9O2S/c1-33-17(13-3-2-4-16(9-13)31-10-14(22)11-31)18(32)26-21-29-28-20(34-21)25-15-5-8-30(12-15)19-23-6-7-24-27-19/h2-4,6-7,9,14-15,17H,5,8,10-12H2,1H3,(H,25,28)(H,26,29,32)/t15-,17-/m1/s1 NSGZZBXIXXUHJV-NVXWUHKLSA-N 416675 (2R)-2-[3-(3-Fluoroazetidin-1-yl)phenyl]-2-methoxy-N-[5-[[(3R)-1-(1,2,4-triazin-3-yl)pyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide and (2R)-2-[3-(3-Fluoroazetidin-1-yl)phenyl]-2-methoxy-N-[5-[[(3R)-1-(1,2,4-triazin-3-yl)pyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide::US10323028, Example 15(b)::US10981904, Example 15(a) Glutaminase kidney isoform, mitochondrial Homo sapiens 1310 US Patent 10.7270/Q20R9RTG aid1803901 US10323028 Nissink, JW; Finlay, MR; Charles, MD 6/18/2019 8/24/2020 AstraZeneca AB http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416675 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5879&target=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416675&enzyme=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search 129161405 433916600 1 MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL 3CZD,3UNW,3UO9,3VOY,3VOZ,3VP0,3VP1,3VP2,3VP3,3VP4,5FI2,5FI6,5FI7,5HL1,6LOX,6UL9,6UMD,7REN,7RGG,8BSK,8BSL,8BSM,8BSN,8GWR Glutaminase kidney isoform, mitochondrial GLSK_HUMAN O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40 835115 CO[C@H](C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2nccnn2)s1)c1cc(OC)cc(OC)c1 InChI=1S/C20H24N8O4S/c1-30-14-8-12(9-15(10-14)31-2)16(32-3)17(29)24-20-27-26-19(33-20)23-13-4-7-28(11-13)18-21-5-6-22-25-18/h5-6,8-10,13,16H,4,7,11H2,1-3H3,(H,23,26)(H,24,27,29)/t13-,16+/m1/s1 ORRGLFGRVLUXNY-CJNGLKHVSA-N 416676 (2S)-2-(3,5-Dimethoxyphenyl)-2-methoxy-N-[5-[[(3R)-1-(1,2,4-triazin-3-yl)pyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide and (2R)-2-(3,5-Dimethoxyphenyl)-2-methoxy-N-[5-[[(3R)-1-(1,2,4-triazin-3-yl)pyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide::US10323028, Example 16(a)::US10981904, Example 16(b) Glutaminase kidney isoform, mitochondrial Homo sapiens 25.2 US Patent 10.7270/Q20R9RTG aid1803901 US10323028 Nissink, JW; Finlay, MR; Charles, MD 6/18/2019 8/24/2020 AstraZeneca AB http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416676 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5879&target=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416676&enzyme=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search 129161481 433916601 1 MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL 3CZD,3UNW,3UO9,3VOY,3VOZ,3VP0,3VP1,3VP2,3VP3,3VP4,5FI2,5FI6,5FI7,5HL1,6LOX,6UL9,6UMD,7REN,7RGG,8BSK,8BSL,8BSM,8BSN,8GWR Glutaminase kidney isoform, mitochondrial GLSK_HUMAN O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40 835116 CO[C@@H](C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2nccnn2)s1)c1cc(OC)cc(OC)c1 InChI=1S/C20H24N8O4S/c1-30-14-8-12(9-15(10-14)31-2)16(32-3)17(29)24-20-27-26-19(33-20)23-13-4-7-28(11-13)18-21-5-6-22-25-18/h5-6,8-10,13,16H,4,7,11H2,1-3H3,(H,23,26)(H,24,27,29)/t13-,16-/m1/s1 ORRGLFGRVLUXNY-CZUORRHYSA-N 416677 (2R)-2-(3,5-Dimethoxyphenyl)-2-methoxy-N-[5-[[(3R)-1-(1,2,4-triazin-3-yl)pyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide and (2R)-2-(3,5-Dimethoxyphenyl)-2-methoxy-N-[5-[[(3R)-1-(1,2,4-triazin-3-yl)pyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide::US10323028, Example 16(b)::US10981904, Example 16(a) Glutaminase kidney isoform, mitochondrial Homo sapiens 689 US Patent 10.7270/Q20R9RTG aid1803901 US10323028 Nissink, JW; Finlay, MR; Charles, MD 6/18/2019 8/24/2020 AstraZeneca AB http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416677 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5879&target=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416677&enzyme=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search 129161465 433916602 1 MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL 3CZD,3UNW,3UO9,3VOY,3VOZ,3VP0,3VP1,3VP2,3VP3,3VP4,5FI2,5FI6,5FI7,5HL1,6LOX,6UL9,6UMD,7REN,7RGG,8BSK,8BSL,8BSM,8BSN,8GWR Glutaminase kidney isoform, mitochondrial GLSK_HUMAN O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40 835117 CCO[C@H](C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2cccnn2)s1)c1cccc(OC(F)F)c1 InChI=1S/C21H23F2N7O3S/c1-2-32-17(13-5-3-6-15(11-13)33-19(22)23)18(31)26-21-29-28-20(34-21)25-14-8-10-30(12-14)16-7-4-9-24-27-16/h3-7,9,11,14,17,19H,2,8,10,12H2,1H3,(H,25,28)(H,26,29,31)/t14-,17+/m1/s1 FXOXNSGEONEWIW-PBHICJAKSA-N 416678 (2S)-[3-(Difluoromethoxy)phenyl]-2-ethoxy-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide and (2R)-[3-(Difluoromethoxy)phenyl]-2-ethoxy-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide::US10323028, Example 17(a)::US10981904, Example 17(b) Glutaminase kidney isoform, mitochondrial Homo sapiens 50.4 US Patent 10.7270/Q20R9RTG aid1803901 US10323028 Nissink, JW; Finlay, MR; Charles, MD 6/18/2019 8/24/2020 AstraZeneca AB http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416678 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5879&target=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416678&enzyme=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search 118554540 433916603 1 MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL 3CZD,3UNW,3UO9,3VOY,3VOZ,3VP0,3VP1,3VP2,3VP3,3VP4,5FI2,5FI6,5FI7,5HL1,6LOX,6UL9,6UMD,7REN,7RGG,8BSK,8BSL,8BSM,8BSN,8GWR Glutaminase kidney isoform, mitochondrial GLSK_HUMAN O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40 835118 CCO[C@@H](C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2cccnn2)s1)c1cccc(OC(F)F)c1 InChI=1S/C21H23F2N7O3S/c1-2-32-17(13-5-3-6-15(11-13)33-19(22)23)18(31)26-21-29-28-20(34-21)25-14-8-10-30(12-14)16-7-4-9-24-27-16/h3-7,9,11,14,17,19H,2,8,10,12H2,1H3,(H,25,28)(H,26,29,31)/t14-,17-/m1/s1 FXOXNSGEONEWIW-RHSMWYFYSA-N 416679 (2R)-[3-(Difluoromethoxy)phenyl]-2-ethoxy-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide and (2R)-[3-(Difluoromethoxy)phenyl]-2-ethoxy-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide::US10323028, Example 17(b)::US10981904, Example 17(a) Glutaminase kidney isoform, mitochondrial Homo sapiens 157 US Patent 10.7270/Q20R9RTG aid1803901 US10323028 Nissink, JW; Finlay, MR; Charles, MD 6/18/2019 8/24/2020 AstraZeneca AB http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416679 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5879&target=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416679&enzyme=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search 118554541 433916604 1 MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL 3CZD,3UNW,3UO9,3VOY,3VOZ,3VP0,3VP1,3VP2,3VP3,3VP4,5FI2,5FI6,5FI7,5HL1,6LOX,6UL9,6UMD,7REN,7RGG,8BSK,8BSL,8BSM,8BSN,8GWR Glutaminase kidney isoform, mitochondrial GLSK_HUMAN O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40 835119 CO[C@H](C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2cccnn2)s1)c1cccc(c1)C1COC1 InChI=1S/C22H25N7O3S/c1-31-19(15-5-2-4-14(10-15)16-12-32-13-16)20(30)25-22-28-27-21(33-22)24-17-7-9-29(11-17)18-6-3-8-23-26-18/h2-6,8,10,16-17,19H,7,9,11-13H2,1H3,(H,24,27)(H,25,28,30)/t17-,19+/m1/s1 MHCDCRNHIYHNIK-MJGOQNOKSA-N 416680 (2S)-2-Methoxy-2-[3-(oxetan-3-yl)phenyl]-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide and (2R)-2-Methoxy-2-[3-(oxetan-3-yl)phenyl]-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide::US10323028, Example 18(a)::US10981904, Example 24 Glutaminase kidney isoform, mitochondrial Homo sapiens 22.6 US Patent 10.7270/Q20R9RTG aid1803901 US10323028 Nissink, JW; Finlay, MR; Charles, MD 6/18/2019 8/24/2020 AstraZeneca AB http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416680 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5879&target=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416680&enzyme=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search 129161401 433916605 1 MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL 3CZD,3UNW,3UO9,3VOY,3VOZ,3VP0,3VP1,3VP2,3VP3,3VP4,5FI2,5FI6,5FI7,5HL1,6LOX,6UL9,6UMD,7REN,7RGG,8BSK,8BSL,8BSM,8BSN,8GWR Glutaminase kidney isoform, mitochondrial GLSK_HUMAN O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40 835120 CO[C@@H](C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2cccnn2)s1)c1cccc(c1)C1COC1 InChI=1S/C22H25N7O3S/c1-31-19(15-5-2-4-14(10-15)16-12-32-13-16)20(30)25-22-28-27-21(33-22)24-17-7-9-29(11-17)18-6-3-8-23-26-18/h2-6,8,10,16-17,19H,7,9,11-13H2,1H3,(H,24,27)(H,25,28,30)/t17-,19-/m1/s1 MHCDCRNHIYHNIK-IEBWSBKVSA-N 416681 (2R)-2-Methoxy-2-[3-(oxetan-3-yl)phenyl]-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide and (2R)-2-Methoxy-2-[3-(oxetan-3-yl)phenyl]-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide::US10323028, Example 18(b)::US10981904, Example 18(a) Glutaminase kidney isoform, mitochondrial Homo sapiens 129 US Patent 10.7270/Q20R9RTG aid1803901 US10323028 Nissink, JW; Finlay, MR; Charles, MD 6/18/2019 8/24/2020 AstraZeneca AB http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416681 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5879&target=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416681&enzyme=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search 129161437 433916606 1 MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL 3CZD,3UNW,3UO9,3VOY,3VOZ,3VP0,3VP1,3VP2,3VP3,3VP4,5FI2,5FI6,5FI7,5HL1,6LOX,6UL9,6UMD,7REN,7RGG,8BSK,8BSL,8BSM,8BSN,8GWR Glutaminase kidney isoform, mitochondrial GLSK_HUMAN O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40 835121 CCO[C@H](C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2cccnn2)s1)c1cccc(OC(F)(F)F)c1 InChI=1S/C21H22F3N7O3S/c1-2-33-17(13-5-3-6-15(11-13)34-21(22,23)24)18(32)27-20-30-29-19(35-20)26-14-8-10-31(12-14)16-7-4-9-25-28-16/h3-7,9,11,14,17H,2,8,10,12H2,1H3,(H,26,29)(H,27,30,32)/t14-,17+/m1/s1 RZACPCSTHBDOLY-PBHICJAKSA-N 416682 (2S)-2-Ethoxy-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]-2-[3-(trifluoromethoxy)phenyl]acetamide and (2R)-2-Ethoxy-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]-2-[3-(trifluoromethoxy)phenyl]acetamide::US10323028, Example 19(a)::US10981904, Example 19(b) Glutaminase kidney isoform, mitochondrial Homo sapiens 40.1 US Patent 10.7270/Q20R9RTG aid1803901 US10323028 Nissink, JW; Finlay, MR; Charles, MD 6/18/2019 8/24/2020 AstraZeneca AB http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416682 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5879&target=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416682&enzyme=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search 118554611 433916607 1 MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL 3CZD,3UNW,3UO9,3VOY,3VOZ,3VP0,3VP1,3VP2,3VP3,3VP4,5FI2,5FI6,5FI7,5HL1,6LOX,6UL9,6UMD,7REN,7RGG,8BSK,8BSL,8BSM,8BSN,8GWR Glutaminase kidney isoform, mitochondrial GLSK_HUMAN O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40 835122 CCO[C@@H](C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2cccnn2)s1)c1cccc(OC(F)(F)F)c1 InChI=1S/C21H22F3N7O3S/c1-2-33-17(13-5-3-6-15(11-13)34-21(22,23)24)18(32)27-20-30-29-19(35-20)26-14-8-10-31(12-14)16-7-4-9-25-28-16/h3-7,9,11,14,17H,2,8,10,12H2,1H3,(H,26,29)(H,27,30,32)/t14-,17-/m1/s1 RZACPCSTHBDOLY-RHSMWYFYSA-N 416683 (2R)-2-Ethoxy-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]-2-[3-(trifluoromethoxy)phenyl]acetamide and (2R)-2-Ethoxy-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]-2-[3-(trifluoromethoxy)phenyl]acetamide::US10323028, Example 19(b)::US10981904, Example 19(a) Glutaminase kidney isoform, mitochondrial Homo sapiens 96.1 US Patent 10.7270/Q20R9RTG aid1803901 US10323028 Nissink, JW; Finlay, MR; Charles, MD 6/18/2019 8/24/2020 AstraZeneca AB http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416683 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5879&target=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416683&enzyme=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search 118542676 433916608 1 MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL 3CZD,3UNW,3UO9,3VOY,3VOZ,3VP0,3VP1,3VP2,3VP3,3VP4,5FI2,5FI6,5FI7,5HL1,6LOX,6UL9,6UMD,7REN,7RGG,8BSK,8BSL,8BSM,8BSN,8GWR Glutaminase kidney isoform, mitochondrial GLSK_HUMAN O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40 835123 CO[C@H](C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2cccnn2)s1)c1ccc(F)c(OC(F)(F)F)c1 InChI=1S/C20H19F4N7O3S/c1-33-16(11-4-5-13(21)14(9-11)34-20(22,23)24)17(32)27-19-30-29-18(35-19)26-12-6-8-31(10-12)15-3-2-7-25-28-15/h2-5,7,9,12,16H,6,8,10H2,1H3,(H,26,29)(H,27,30,32)/t12-,16+/m1/s1 WDDBMFLLFAMIRF-WBMJQRKESA-N 416684 (2S)-2-[4-Fluoro-3-(trifluoromethoxy)phenyl]-2-methoxy-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide and (2S)-2-[4-Fluoro-3-(trifluoromethoxy)phenyl]-2-methoxy-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide::US10323028, Example 20(a)::US10981904, Example 20(b) Glutaminase kidney isoform, mitochondrial Homo sapiens 69.3 US Patent 10.7270/Q20R9RTG aid1803901 US10323028 Nissink, JW; Finlay, MR; Charles, MD 6/18/2019 8/24/2020 AstraZeneca AB http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416684 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5879&target=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416684&enzyme=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search 129161474 433916609 1 MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL 3CZD,3UNW,3UO9,3VOY,3VOZ,3VP0,3VP1,3VP2,3VP3,3VP4,5FI2,5FI6,5FI7,5HL1,6LOX,6UL9,6UMD,7REN,7RGG,8BSK,8BSL,8BSM,8BSN,8GWR Glutaminase kidney isoform, mitochondrial GLSK_HUMAN O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40 835124 CO[C@@H](C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2cccnn2)s1)c1ccc(F)c(OC(F)(F)F)c1 InChI=1S/C20H19F4N7O3S/c1-33-16(11-4-5-13(21)14(9-11)34-20(22,23)24)17(32)27-19-30-29-18(35-19)26-12-6-8-31(10-12)15-3-2-7-25-28-15/h2-5,7,9,12,16H,6,8,10H2,1H3,(H,26,29)(H,27,30,32)/t12-,16-/m1/s1 WDDBMFLLFAMIRF-MLGOLLRUSA-N 416685 (2R)-2-[4-Fluoro-3-(trifluoromethoxy)phenyl]-2-methoxy-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide and (2S)-2-[4-Fluoro-3-(trifluoromethoxy)phenyl]-2-methoxy-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide::US10323028, Example 20(b)::US10981904, Example 20(a) Glutaminase kidney isoform, mitochondrial Homo sapiens 64.1 US Patent 10.7270/Q20R9RTG aid1803901 US10323028 Nissink, JW; Finlay, MR; Charles, MD 6/18/2019 8/24/2020 AstraZeneca AB http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416685 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5879&target=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416685&enzyme=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search 129161411 433916610 1 MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL 3CZD,3UNW,3UO9,3VOY,3VOZ,3VP0,3VP1,3VP2,3VP3,3VP4,5FI2,5FI6,5FI7,5HL1,6LOX,6UL9,6UMD,7REN,7RGG,8BSK,8BSL,8BSM,8BSN,8GWR Glutaminase kidney isoform, mitochondrial GLSK_HUMAN O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40 835125 CO[C@H](C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2cccnn2)s1)c1cc(OC)cc(OC)c1 InChI=1S/C21H25N7O4S/c1-30-15-9-13(10-16(11-15)31-2)18(32-3)19(29)24-21-27-26-20(33-21)23-14-6-8-28(12-14)17-5-4-7-22-25-17/h4-5,7,9-11,14,18H,6,8,12H2,1-3H3,(H,23,26)(H,24,27,29)/t14-,18+/m1/s1 MCWGAWNVXRUZFM-KDOFPFPSSA-N 416686 (2S)-2-(3,5-Dimethoxyphenyl)-2-methoxy-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide and (2R)-2-(3,5-Dimethoxyphenyl)-2-methoxy-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide::US10323028, Example 21(a)::US10981904, Example 44 Glutaminase kidney isoform, mitochondrial Homo sapiens 20.0 US Patent 10.7270/Q20R9RTG aid1803901 US10323028 Nissink, JW; Finlay, MR; Charles, MD 6/18/2019 8/24/2020 AstraZeneca AB http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416686 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5879&target=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416686&enzyme=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search 129161439 433916611 1 MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL 3CZD,3UNW,3UO9,3VOY,3VOZ,3VP0,3VP1,3VP2,3VP3,3VP4,5FI2,5FI6,5FI7,5HL1,6LOX,6UL9,6UMD,7REN,7RGG,8BSK,8BSL,8BSM,8BSN,8GWR Glutaminase kidney isoform, mitochondrial GLSK_HUMAN O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40 835126 CO[C@@H](C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2cccnn2)s1)c1cc(OC)cc(OC)c1 InChI=1S/C21H25N7O4S/c1-30-15-9-13(10-16(11-15)31-2)18(32-3)19(29)24-21-27-26-20(33-21)23-14-6-8-28(12-14)17-5-4-7-22-25-17/h4-5,7,9-11,14,18H,6,8,12H2,1-3H3,(H,23,26)(H,24,27,29)/t14-,18-/m1/s1 MCWGAWNVXRUZFM-RDTXWAMCSA-N 416687 (2R)-2-(3,5-Dimethoxyphenyl)-2-methoxy-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide and (2R)-2-(3,5-Dimethoxyphenyl)-2-methoxy-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide::US10323028, Example 21(b)::US10981904, Example 43 Glutaminase kidney isoform, mitochondrial Homo sapiens 48.2 US Patent 10.7270/Q20R9RTG aid1803901 US10323028 Nissink, JW; Finlay, MR; Charles, MD 6/18/2019 8/24/2020 AstraZeneca AB http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416687 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5879&target=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416687&enzyme=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search 129161429 433916612 1 MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL 3CZD,3UNW,3UO9,3VOY,3VOZ,3VP0,3VP1,3VP2,3VP3,3VP4,5FI2,5FI6,5FI7,5HL1,6LOX,6UL9,6UMD,7REN,7RGG,8BSK,8BSL,8BSM,8BSN,8GWR Glutaminase kidney isoform, mitochondrial GLSK_HUMAN O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40 835127 CCO[C@H](C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2cccnn2)s1)c1cccc(c1)N1CC(C1)OC InChI=1S/C24H30N8O3S/c1-3-35-21(16-6-4-7-18(12-16)32-14-19(15-32)34-2)22(33)27-24-30-29-23(36-24)26-17-9-11-31(13-17)20-8-5-10-25-28-20/h4-8,10,12,17,19,21H,3,9,11,13-15H2,1-2H3,(H,26,29)(H,27,30,33)/t17-,21+/m1/s1 WAPXAOQFTGRVPA-UTKZUKDTSA-N 416688 (2S)-2-ethoxy-2-[3-(3-methoxyazetidin-1-yl)phenyl]-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide and (2R)-2-ethoxy-2-[3-(3-methoxyazetidin-1-yl)phenyl]-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide::US10323028, Example 22(a)::US10981904, Example 33 Glutaminase kidney isoform, mitochondrial Homo sapiens 68.5 US Patent 10.7270/Q20R9RTG aid1803901 US10323028 Nissink, JW; Finlay, MR; Charles, MD 6/18/2019 8/24/2020 AstraZeneca AB http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416688 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5879&target=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416688&enzyme=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search 129161480 433916613 1 MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL 3CZD,3UNW,3UO9,3VOY,3VOZ,3VP0,3VP1,3VP2,3VP3,3VP4,5FI2,5FI6,5FI7,5HL1,6LOX,6UL9,6UMD,7REN,7RGG,8BSK,8BSL,8BSM,8BSN,8GWR Glutaminase kidney isoform, mitochondrial GLSK_HUMAN O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40 835128 CCO[C@@H](C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2cccnn2)s1)c1cccc(c1)N1CC(C1)OC InChI=1S/C24H30N8O3S/c1-3-35-21(16-6-4-7-18(12-16)32-14-19(15-32)34-2)22(33)27-24-30-29-23(36-24)26-17-9-11-31(13-17)20-8-5-10-25-28-20/h4-8,10,12,17,19,21H,3,9,11,13-15H2,1-2H3,(H,26,29)(H,27,30,33)/t17-,21-/m1/s1 WAPXAOQFTGRVPA-DYESRHJHSA-N 416689 (2R)-2-ethoxy-2-[3-(3-methoxyazetidin-1-yl)phenyl]-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide and (2R)-2-ethoxy-2-[3-(3-methoxyazetidin-1-yl)phenyl]-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide::US10323028, Example 22(b)::US10981904, Example 34 Glutaminase kidney isoform, mitochondrial Homo sapiens 131 US Patent 10.7270/Q20R9RTG aid1803901 US10323028 Nissink, JW; Finlay, MR; Charles, MD 6/18/2019 8/24/2020 AstraZeneca AB http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416689 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5879&target=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416689&enzyme=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search 129161445 433916614 1 MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL 3CZD,3UNW,3UO9,3VOY,3VOZ,3VP0,3VP1,3VP2,3VP3,3VP4,5FI2,5FI6,5FI7,5HL1,6LOX,6UL9,6UMD,7REN,7RGG,8BSK,8BSL,8BSM,8BSN,8GWR Glutaminase kidney isoform, mitochondrial GLSK_HUMAN O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40 835129 COC(C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2cccnn2)s1)c1cc(OC)cc(OC)c1 InChI=1S/C21H25N7O4S/c1-30-15-9-13(10-16(11-15)31-2)18(32-3)19(29)24-21-27-26-20(33-21)23-14-6-8-28(12-14)17-5-4-7-22-25-17/h4-5,7,9-11,14,18H,6,8,12H2,1-3H3,(H,23,26)(H,24,27,29)/t14-,18?/m1/s1 MCWGAWNVXRUZFM-IKJXHCRLSA-N 416690 2-(3,5-dimethoxyphenyl)-2-methoxy-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide::US10323028, Example 23::US10323028, Example 43::US10323028, Example 44 Glutaminase kidney isoform, mitochondrial Homo sapiens 48.2 US Patent 10.7270/Q20R9RTG aid1803901 US10323028 Nissink, JW; Finlay, MR; Charles, MD 6/18/2019 8/24/2020 AstraZeneca AB http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416690 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5879&target=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416690&enzyme=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search 154584195 433916615 1 MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL 3CZD,3UNW,3UO9,3VOY,3VOZ,3VP0,3VP1,3VP2,3VP3,3VP4,5FI2,5FI6,5FI7,5HL1,6LOX,6UL9,6UMD,7REN,7RGG,8BSK,8BSL,8BSM,8BSN,8GWR Glutaminase kidney isoform, mitochondrial GLSK_HUMAN O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40 835130 COC(C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2nccnn2)s1)c1cccc(c1)C1COC1 InChI=1S/C21H24N8O3S/c1-31-17(14-4-2-3-13(9-14)15-11-32-12-15)18(30)25-21-28-27-20(33-21)24-16-5-8-29(10-16)19-22-6-7-23-26-19/h2-4,6-7,9,15-17H,5,8,10-12H2,1H3,(H,24,27)(H,25,28,30)/t16-,17?/m1/s1 BHHRMKUIMYCYEF-TZHYSIJRSA-N 416691 2-methoxy-2-[3-(oxetan-3-yl)phenyl]-N-[5-[[(3R)-1-(1,2,4-triazin-3-yl)pyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide::US10323028, Example 24::US10323028, Example 25 Glutaminase kidney isoform, mitochondrial Homo sapiens 52.6 US Patent 10.7270/Q20R9RTG aid1803901 US10323028 Nissink, JW; Finlay, MR; Charles, MD 6/18/2019 8/24/2020 AstraZeneca AB http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416691 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5879&target=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416691&enzyme=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search 154584196 433916616 1 MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL 3CZD,3UNW,3UO9,3VOY,3VOZ,3VP0,3VP1,3VP2,3VP3,3VP4,5FI2,5FI6,5FI7,5HL1,6LOX,6UL9,6UMD,7REN,7RGG,8BSK,8BSL,8BSM,8BSN,8GWR Glutaminase kidney isoform, mitochondrial GLSK_HUMAN O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40 835131 COC(C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2nccnn2)s1)c1cccc(c1)C1COC1 InChI=1S/C21H24N8O3S/c1-31-17(14-4-2-3-13(9-14)15-11-32-12-15)18(30)25-21-28-27-20(33-21)24-16-5-8-29(10-16)19-22-6-7-23-26-19/h2-4,6-7,9,15-17H,5,8,10-12H2,1H3,(H,24,27)(H,25,28,30)/t16-,17?/m1/s1 BHHRMKUIMYCYEF-TZHYSIJRSA-N 416691 2-methoxy-2-[3-(oxetan-3-yl)phenyl]-N-[5-[[(3R)-1-(1,2,4-triazin-3-yl)pyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide::US10323028, Example 24::US10323028, Example 25 Glutaminase kidney isoform, mitochondrial Homo sapiens 1840 US Patent 10.7270/Q20R9RTG aid1803901 US10323028 Nissink, JW; Finlay, MR; Charles, MD 6/18/2019 8/24/2020 AstraZeneca AB http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416691 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5879&target=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416691&enzyme=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search 154584196 433916616 1 MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL 3CZD,3UNW,3UO9,3VOY,3VOZ,3VP0,3VP1,3VP2,3VP3,3VP4,5FI2,5FI6,5FI7,5HL1,6LOX,6UL9,6UMD,7REN,7RGG,8BSK,8BSL,8BSM,8BSN,8GWR Glutaminase kidney isoform, mitochondrial GLSK_HUMAN O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40 835132 COC(C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2ccc(F)nn2)s1)c1cc(OC)cc(OC)c1 InChI=1S/C21H24FN7O4S/c1-31-14-8-12(9-15(10-14)32-2)18(33-3)19(30)24-21-28-27-20(34-21)23-13-6-7-29(11-13)17-5-4-16(22)25-26-17/h4-5,8-10,13,18H,6-7,11H2,1-3H3,(H,23,27)(H,24,28,30)/t13-,18?/m1/s1 RBFZHXNSAXVLDS-YJJYDOSJSA-N 416693 2-(3,5-dimethoxyphenyl)-N-[5-[[(3R)-1-(6-fluoropyridazin-3-yl)pyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]-2-methoxy-acetamide::US10323028, Example 26 Glutaminase kidney isoform, mitochondrial Homo sapiens 23.5 US Patent 10.7270/Q20R9RTG aid1803901 US10323028 Nissink, JW; Finlay, MR; Charles, MD 6/18/2019 8/24/2020 AstraZeneca AB http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416693 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5879&target=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416693&enzyme=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search 154584197 433916617 1 MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL 3CZD,3UNW,3UO9,3VOY,3VOZ,3VP0,3VP1,3VP2,3VP3,3VP4,5FI2,5FI6,5FI7,5HL1,6LOX,6UL9,6UMD,7REN,7RGG,8BSK,8BSL,8BSM,8BSN,8GWR Glutaminase kidney isoform, mitochondrial GLSK_HUMAN O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40 835133 COC(C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2ccc(F)nn2)s1)c1cccc(c1)N1CC(F)C1 InChI=1S/C22H24F2N8O2S/c1-34-19(13-3-2-4-16(9-13)32-10-14(23)11-32)20(33)26-22-30-29-21(35-22)25-15-7-8-31(12-15)18-6-5-17(24)27-28-18/h2-6,9,14-15,19H,7-8,10-12H2,1H3,(H,25,29)(H,26,30,33)/t15-,19?/m1/s1 JWANLTKYUMFDIQ-NYRJJRHWSA-N 416694 2-[3-(3-fluoroazetidin-1-yl)phenyl]-N-[5-[[(3R)-1-(6-fluoropyridazin-3-yl)pyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]-2-methoxy-acetamide::US10323028, Example 27::US10323028, Example 28 Glutaminase kidney isoform, mitochondrial Homo sapiens 149 US Patent 10.7270/Q20R9RTG aid1803901 US10323028 Nissink, JW; Finlay, MR; Charles, MD 6/18/2019 8/24/2020 AstraZeneca AB http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416694 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5879&target=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416694&enzyme=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search 154584198 433916618 1 MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL 3CZD,3UNW,3UO9,3VOY,3VOZ,3VP0,3VP1,3VP2,3VP3,3VP4,5FI2,5FI6,5FI7,5HL1,6LOX,6UL9,6UMD,7REN,7RGG,8BSK,8BSL,8BSM,8BSN,8GWR Glutaminase kidney isoform, mitochondrial GLSK_HUMAN O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40 835134 COC(C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2ccc(F)nn2)s1)c1cccc(c1)N1CC(F)C1 InChI=1S/C22H24F2N8O2S/c1-34-19(13-3-2-4-16(9-13)32-10-14(23)11-32)20(33)26-22-30-29-21(35-22)25-15-7-8-31(12-15)18-6-5-17(24)27-28-18/h2-6,9,14-15,19H,7-8,10-12H2,1H3,(H,25,29)(H,26,30,33)/t15-,19?/m1/s1 JWANLTKYUMFDIQ-NYRJJRHWSA-N 416694 2-[3-(3-fluoroazetidin-1-yl)phenyl]-N-[5-[[(3R)-1-(6-fluoropyridazin-3-yl)pyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]-2-methoxy-acetamide::US10323028, Example 27::US10323028, Example 28 Glutaminase kidney isoform, mitochondrial Homo sapiens 195 US Patent 10.7270/Q20R9RTG aid1803901 US10323028 Nissink, JW; Finlay, MR; Charles, MD 6/18/2019 8/24/2020 AstraZeneca AB http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416694 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5879&target=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416694&enzyme=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search 154584198 433916618 1 MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL 3CZD,3UNW,3UO9,3VOY,3VOZ,3VP0,3VP1,3VP2,3VP3,3VP4,5FI2,5FI6,5FI7,5HL1,6LOX,6UL9,6UMD,7REN,7RGG,8BSK,8BSL,8BSM,8BSN,8GWR Glutaminase kidney isoform, mitochondrial GLSK_HUMAN O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40 835135 CCOC(C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2cccnn2)s1)c1cccc(c1)N1CC(F)(F)C1 InChI=1S/C23H26F2N8O2S/c1-2-35-19(15-5-3-6-17(11-15)33-13-23(24,25)14-33)20(34)28-22-31-30-21(36-22)27-16-8-10-32(12-16)18-7-4-9-26-29-18/h3-7,9,11,16,19H,2,8,10,12-14H2,1H3,(H,27,30)(H,28,31,34)/t16-,19?/m1/s1 PROIAWBRPAQRJA-VTBWFHPJSA-N 416696 2-[3-(3,3-difluoroazetidin-1-yl)phenyl]-2-ethoxy-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide::US10323028, Example 29::US10323028, Example 30 Glutaminase kidney isoform, mitochondrial Homo sapiens 51.1 US Patent 10.7270/Q20R9RTG aid1803901 US10323028 Nissink, JW; Finlay, MR; Charles, MD 6/18/2019 8/24/2020 AstraZeneca AB http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416696 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5879&target=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416696&enzyme=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search 154584199 433916619 1 MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL 3CZD,3UNW,3UO9,3VOY,3VOZ,3VP0,3VP1,3VP2,3VP3,3VP4,5FI2,5FI6,5FI7,5HL1,6LOX,6UL9,6UMD,7REN,7RGG,8BSK,8BSL,8BSM,8BSN,8GWR Glutaminase kidney isoform, mitochondrial GLSK_HUMAN O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40 835136 CCOC(C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2cccnn2)s1)c1cccc(c1)N1CC(F)(F)C1 InChI=1S/C23H26F2N8O2S/c1-2-35-19(15-5-3-6-17(11-15)33-13-23(24,25)14-33)20(34)28-22-31-30-21(36-22)27-16-8-10-32(12-16)18-7-4-9-26-29-18/h3-7,9,11,16,19H,2,8,10,12-14H2,1H3,(H,27,30)(H,28,31,34)/t16-,19?/m1/s1 PROIAWBRPAQRJA-VTBWFHPJSA-N 416696 2-[3-(3,3-difluoroazetidin-1-yl)phenyl]-2-ethoxy-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide::US10323028, Example 29::US10323028, Example 30 Glutaminase kidney isoform, mitochondrial Homo sapiens 1370 US Patent 10.7270/Q20R9RTG aid1803901 US10323028 Nissink, JW; Finlay, MR; Charles, MD 6/18/2019 8/24/2020 AstraZeneca AB http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416696 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5879&target=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416696&enzyme=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search 154584199 433916619 1 MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL 3CZD,3UNW,3UO9,3VOY,3VOZ,3VP0,3VP1,3VP2,3VP3,3VP4,5FI2,5FI6,5FI7,5HL1,6LOX,6UL9,6UMD,7REN,7RGG,8BSK,8BSL,8BSM,8BSN,8GWR Glutaminase kidney isoform, mitochondrial GLSK_HUMAN O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40 835137 CCOC(C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2cccnn2)s1)c1cccc(c1)N1CC(F)C1 InChI=1S/C23H27FN8O2S/c1-2-34-20(15-5-3-6-18(11-15)32-12-16(24)13-32)21(33)27-23-30-29-22(35-23)26-17-8-10-31(14-17)19-7-4-9-25-28-19/h3-7,9,11,16-17,20H,2,8,10,12-14H2,1H3,(H,26,29)(H,27,30,33)/t17-,20?/m1/s1 DBVUFYPJNUMYSJ-DIAVIDTQSA-N 416698 2-ethoxy-2-[3-(3-fluoroazetidin-1-yl)phenyl]-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide::US10323028, Example 31::US10323028, Example 32 Glutaminase kidney isoform, mitochondrial Homo sapiens 96.8 US Patent 10.7270/Q20R9RTG aid1803901 US10323028 Nissink, JW; Finlay, MR; Charles, MD 6/18/2019 8/24/2020 AstraZeneca AB http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416698 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5879&target=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416698&enzyme=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search 154584200 433916620 1 MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL 3CZD,3UNW,3UO9,3VOY,3VOZ,3VP0,3VP1,3VP2,3VP3,3VP4,5FI2,5FI6,5FI7,5HL1,6LOX,6UL9,6UMD,7REN,7RGG,8BSK,8BSL,8BSM,8BSN,8GWR Glutaminase kidney isoform, mitochondrial GLSK_HUMAN O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40 835138 CCOC(C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2cccnn2)s1)c1cccc(c1)N1CC(F)C1 InChI=1S/C23H27FN8O2S/c1-2-34-20(15-5-3-6-18(11-15)32-12-16(24)13-32)21(33)27-23-30-29-22(35-23)26-17-8-10-31(14-17)19-7-4-9-25-28-19/h3-7,9,11,16-17,20H,2,8,10,12-14H2,1H3,(H,26,29)(H,27,30,33)/t17-,20?/m1/s1 DBVUFYPJNUMYSJ-DIAVIDTQSA-N 416698 2-ethoxy-2-[3-(3-fluoroazetidin-1-yl)phenyl]-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide::US10323028, Example 31::US10323028, Example 32 Glutaminase kidney isoform, mitochondrial Homo sapiens 188 US Patent 10.7270/Q20R9RTG aid1803901 US10323028 Nissink, JW; Finlay, MR; Charles, MD 6/18/2019 8/24/2020 AstraZeneca AB http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416698 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5879&target=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416698&enzyme=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search 154584200 433916620 1 MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL 3CZD,3UNW,3UO9,3VOY,3VOZ,3VP0,3VP1,3VP2,3VP3,3VP4,5FI2,5FI6,5FI7,5HL1,6LOX,6UL9,6UMD,7REN,7RGG,8BSK,8BSL,8BSM,8BSN,8GWR Glutaminase kidney isoform, mitochondrial GLSK_HUMAN O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40 835139 CCOC(C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2cccnn2)s1)c1cccc(c1)N1CC(C1)OC InChI=1S/C24H30N8O3S/c1-3-35-21(16-6-4-7-18(12-16)32-14-19(15-32)34-2)22(33)27-24-30-29-23(36-24)26-17-9-11-31(13-17)20-8-5-10-25-28-20/h4-8,10,12,17,19,21H,3,9,11,13-15H2,1-2H3,(H,26,29)(H,27,30,33)/t17-,21?/m1/s1 WAPXAOQFTGRVPA-OQHSHRKDSA-N 416700 2-ethoxy-2-[3-(3-methoxyazetidin-1-yl)phenyl]-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide::US10323028, Example 33::US10323028, Example 34 Glutaminase kidney isoform, mitochondrial Homo sapiens 68.5 US Patent 10.7270/Q20R9RTG aid1803901 US10323028 Nissink, JW; Finlay, MR; Charles, MD 6/18/2019 8/24/2020 AstraZeneca AB http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416700 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5879&target=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416700&enzyme=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search 154584201 433916621 1 MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL 3CZD,3UNW,3UO9,3VOY,3VOZ,3VP0,3VP1,3VP2,3VP3,3VP4,5FI2,5FI6,5FI7,5HL1,6LOX,6UL9,6UMD,7REN,7RGG,8BSK,8BSL,8BSM,8BSN,8GWR Glutaminase kidney isoform, mitochondrial GLSK_HUMAN O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40 835140 CCOC(C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2cccnn2)s1)c1cccc(c1)N1CC(C1)OC InChI=1S/C24H30N8O3S/c1-3-35-21(16-6-4-7-18(12-16)32-14-19(15-32)34-2)22(33)27-24-30-29-23(36-24)26-17-9-11-31(13-17)20-8-5-10-25-28-20/h4-8,10,12,17,19,21H,3,9,11,13-15H2,1-2H3,(H,26,29)(H,27,30,33)/t17-,21?/m1/s1 WAPXAOQFTGRVPA-OQHSHRKDSA-N 416700 2-ethoxy-2-[3-(3-methoxyazetidin-1-yl)phenyl]-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide::US10323028, Example 33::US10323028, Example 34 Glutaminase kidney isoform, mitochondrial Homo sapiens 131 US Patent 10.7270/Q20R9RTG aid1803901 US10323028 Nissink, JW; Finlay, MR; Charles, MD 6/18/2019 8/24/2020 AstraZeneca AB http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416700 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5879&target=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416700&enzyme=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search 154584201 433916621 1 MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL 3CZD,3UNW,3UO9,3VOY,3VOZ,3VP0,3VP1,3VP2,3VP3,3VP4,5FI2,5FI6,5FI7,5HL1,6LOX,6UL9,6UMD,7REN,7RGG,8BSK,8BSL,8BSM,8BSN,8GWR Glutaminase kidney isoform, mitochondrial GLSK_HUMAN O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40 835141 COC(C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2ccc(C)nn2)s1)c1cccc(c1)N1CC(F)C1 InChI=1S/C23H27FN8O2S/c1-14-6-7-19(28-27-14)31-9-8-17(13-31)25-22-29-30-23(35-22)26-21(33)20(34-2)15-4-3-5-18(10-15)32-11-16(24)12-32/h3-7,10,16-17,20H,8-9,11-13H2,1-2H3,(H,25,29)(H,26,30,33)/t17-,20?/m1/s1 JRDLBHDZQLKUMB-DIAVIDTQSA-N 416702 2-[3-(3-fluoroazetidin-1-yl)phenyl]-2-methoxy-N-[5-[[(3R)-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide::US10323028, Example 35::US10323028, Example 36 Glutaminase kidney isoform, mitochondrial Homo sapiens 77.0 US Patent 10.7270/Q20R9RTG aid1803901 US10323028 Nissink, JW; Finlay, MR; Charles, MD 6/18/2019 8/24/2020 AstraZeneca AB http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416702 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5879&target=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416702&enzyme=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search 154584202 433916622 1 MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL 3CZD,3UNW,3UO9,3VOY,3VOZ,3VP0,3VP1,3VP2,3VP3,3VP4,5FI2,5FI6,5FI7,5HL1,6LOX,6UL9,6UMD,7REN,7RGG,8BSK,8BSL,8BSM,8BSN,8GWR Glutaminase kidney isoform, mitochondrial GLSK_HUMAN O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40 835142 COC(C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2ccc(C)nn2)s1)c1cccc(c1)N1CC(F)C1 InChI=1S/C23H27FN8O2S/c1-14-6-7-19(28-27-14)31-9-8-17(13-31)25-22-29-30-23(35-22)26-21(33)20(34-2)15-4-3-5-18(10-15)32-11-16(24)12-32/h3-7,10,16-17,20H,8-9,11-13H2,1-2H3,(H,25,29)(H,26,30,33)/t17-,20?/m1/s1 JRDLBHDZQLKUMB-DIAVIDTQSA-N 416702 2-[3-(3-fluoroazetidin-1-yl)phenyl]-2-methoxy-N-[5-[[(3R)-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide::US10323028, Example 35::US10323028, Example 36 Glutaminase kidney isoform, mitochondrial Homo sapiens 612 US Patent 10.7270/Q20R9RTG aid1803901 US10323028 Nissink, JW; Finlay, MR; Charles, MD 6/18/2019 8/24/2020 AstraZeneca AB http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416702 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5879&target=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416702&enzyme=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search 154584202 433916622 1 MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL 3CZD,3UNW,3UO9,3VOY,3VOZ,3VP0,3VP1,3VP2,3VP3,3VP4,5FI2,5FI6,5FI7,5HL1,6LOX,6UL9,6UMD,7REN,7RGG,8BSK,8BSL,8BSM,8BSN,8GWR Glutaminase kidney isoform, mitochondrial GLSK_HUMAN O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40 835143 COC(C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2cccnn2)s1)c1ccc(F)c(c1)N1CC(F)(F)C1 InChI=1S/C22H23F3N8O2S/c1-35-18(13-4-5-15(23)16(9-13)33-11-22(24,25)12-33)19(34)28-21-31-30-20(36-21)27-14-6-8-32(10-14)17-3-2-7-26-29-17/h2-5,7,9,14,18H,6,8,10-12H2,1H3,(H,27,30)(H,28,31,34)/t14-,18?/m1/s1 DKBGSSLUEJEXRP-IKJXHCRLSA-N 416704 2-[3-(3,3-difluoroazetidin-1-yl)-4-fluoro-phenyl]-2-methoxy-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide::US10323028, Example 37::US10323028, Example 38 Glutaminase kidney isoform, mitochondrial Homo sapiens 147 US Patent 10.7270/Q20R9RTG aid1803901 US10323028 Nissink, JW; Finlay, MR; Charles, MD 6/18/2019 8/24/2020 AstraZeneca AB http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416704 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5879&target=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416704&enzyme=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search 154584203 433916623 1 MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL 3CZD,3UNW,3UO9,3VOY,3VOZ,3VP0,3VP1,3VP2,3VP3,3VP4,5FI2,5FI6,5FI7,5HL1,6LOX,6UL9,6UMD,7REN,7RGG,8BSK,8BSL,8BSM,8BSN,8GWR Glutaminase kidney isoform, mitochondrial GLSK_HUMAN O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40 835144 COC(C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2cccnn2)s1)c1ccc(F)c(c1)N1CC(F)(F)C1 InChI=1S/C22H23F3N8O2S/c1-35-18(13-4-5-15(23)16(9-13)33-11-22(24,25)12-33)19(34)28-21-31-30-20(36-21)27-14-6-8-32(10-14)17-3-2-7-26-29-17/h2-5,7,9,14,18H,6,8,10-12H2,1H3,(H,27,30)(H,28,31,34)/t14-,18?/m1/s1 DKBGSSLUEJEXRP-IKJXHCRLSA-N 416704 2-[3-(3,3-difluoroazetidin-1-yl)-4-fluoro-phenyl]-2-methoxy-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide::US10323028, Example 37::US10323028, Example 38 Glutaminase kidney isoform, mitochondrial Homo sapiens 190 US Patent 10.7270/Q20R9RTG aid1803901 US10323028 Nissink, JW; Finlay, MR; Charles, MD 6/18/2019 8/24/2020 AstraZeneca AB http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416704 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5879&target=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416704&enzyme=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search 154584203 433916623 1 MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL 3CZD,3UNW,3UO9,3VOY,3VOZ,3VP0,3VP1,3VP2,3VP3,3VP4,5FI2,5FI6,5FI7,5HL1,6LOX,6UL9,6UMD,7REN,7RGG,8BSK,8BSL,8BSM,8BSN,8GWR Glutaminase kidney isoform, mitochondrial GLSK_HUMAN O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40 835145 COC(C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2ccc(C)nn2)s1)c1cccc(c1)N1CC(F)(F)C1 InChI=1S/C23H26F2N8O2S/c1-14-6-7-18(29-28-14)32-9-8-16(11-32)26-21-30-31-22(36-21)27-20(34)19(35-2)15-4-3-5-17(10-15)33-12-23(24,25)13-33/h3-7,10,16,19H,8-9,11-13H2,1-2H3,(H,26,30)(H,27,31,34)/t16-,19?/m1/s1 BXMRDNIQPFKEHK-VTBWFHPJSA-N 416706 2-[3-(3,3-difluoroazetidin-1-yl)phenyl]-2-methoxy-N-[5-[[(3R)-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide::US10323028, Example 39::US10323028, Example 40 Glutaminase kidney isoform, mitochondrial Homo sapiens 130 US Patent 10.7270/Q20R9RTG aid1803901 US10323028 Nissink, JW; Finlay, MR; Charles, MD 6/18/2019 8/24/2020 AstraZeneca AB http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416706 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5879&target=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416706&enzyme=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search 154584204 433916624 1 MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL 3CZD,3UNW,3UO9,3VOY,3VOZ,3VP0,3VP1,3VP2,3VP3,3VP4,5FI2,5FI6,5FI7,5HL1,6LOX,6UL9,6UMD,7REN,7RGG,8BSK,8BSL,8BSM,8BSN,8GWR Glutaminase kidney isoform, mitochondrial GLSK_HUMAN O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40 835146 COC(C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2ccc(C)nn2)s1)c1cccc(c1)N1CC(F)(F)C1 InChI=1S/C23H26F2N8O2S/c1-14-6-7-18(29-28-14)32-9-8-16(11-32)26-21-30-31-22(36-21)27-20(34)19(35-2)15-4-3-5-17(10-15)33-12-23(24,25)13-33/h3-7,10,16,19H,8-9,11-13H2,1-2H3,(H,26,30)(H,27,31,34)/t16-,19?/m1/s1 BXMRDNIQPFKEHK-VTBWFHPJSA-N 416706 2-[3-(3,3-difluoroazetidin-1-yl)phenyl]-2-methoxy-N-[5-[[(3R)-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide::US10323028, Example 39::US10323028, Example 40 Glutaminase kidney isoform, mitochondrial Homo sapiens 311 US Patent 10.7270/Q20R9RTG aid1803901 US10323028 Nissink, JW; Finlay, MR; Charles, MD 6/18/2019 8/24/2020 AstraZeneca AB http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416706 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5879&target=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416706&enzyme=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search 154584204 433916624 1 MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL 3CZD,3UNW,3UO9,3VOY,3VOZ,3VP0,3VP1,3VP2,3VP3,3VP4,5FI2,5FI6,5FI7,5HL1,6LOX,6UL9,6UMD,7REN,7RGG,8BSK,8BSL,8BSM,8BSN,8GWR Glutaminase kidney isoform, mitochondrial GLSK_HUMAN O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40 835147 COC(C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2ccc(F)nn2)s1)c1cccc(c1)N1CC(F)(F)C1 InChI=1S/C22H23F3N8O2S/c1-35-18(13-3-2-4-15(9-13)33-11-22(24,25)12-33)19(34)27-21-31-30-20(36-21)26-14-7-8-32(10-14)17-6-5-16(23)28-29-17/h2-6,9,14,18H,7-8,10-12H2,1H3,(H,26,30)(H,27,31,34)/t14-,18?/m1/s1 UOTPGUKGAKLZBD-IKJXHCRLSA-N 416708 2-[3-(3,3-difluoroazetidin-1-yl)phenyl]-N-[5-[[(3R)-1-(6-fluoropyridazin-3-yl)pyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]-2-methoxy-acetamide::US10323028, Example 41::US10323028, Example 42 Glutaminase kidney isoform, mitochondrial Homo sapiens 46.7 US Patent 10.7270/Q20R9RTG aid1803901 US10323028 Nissink, JW; Finlay, MR; Charles, MD 6/18/2019 8/24/2020 AstraZeneca AB http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416708 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5879&target=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416708&enzyme=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search 154584205 433916625 1 MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL 3CZD,3UNW,3UO9,3VOY,3VOZ,3VP0,3VP1,3VP2,3VP3,3VP4,5FI2,5FI6,5FI7,5HL1,6LOX,6UL9,6UMD,7REN,7RGG,8BSK,8BSL,8BSM,8BSN,8GWR Glutaminase kidney isoform, mitochondrial GLSK_HUMAN O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40 835148 COC(C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2ccc(F)nn2)s1)c1cccc(c1)N1CC(F)(F)C1 InChI=1S/C22H23F3N8O2S/c1-35-18(13-3-2-4-15(9-13)33-11-22(24,25)12-33)19(34)27-21-31-30-20(36-21)26-14-7-8-32(10-14)17-6-5-16(23)28-29-17/h2-6,9,14,18H,7-8,10-12H2,1H3,(H,26,30)(H,27,31,34)/t14-,18?/m1/s1 UOTPGUKGAKLZBD-IKJXHCRLSA-N 416708 2-[3-(3,3-difluoroazetidin-1-yl)phenyl]-N-[5-[[(3R)-1-(6-fluoropyridazin-3-yl)pyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]-2-methoxy-acetamide::US10323028, Example 41::US10323028, Example 42 Glutaminase kidney isoform, mitochondrial Homo sapiens 206 US Patent 10.7270/Q20R9RTG aid1803901 US10323028 Nissink, JW; Finlay, MR; Charles, MD 6/18/2019 8/24/2020 AstraZeneca AB http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416708 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5879&target=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416708&enzyme=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search 154584205 433916625 1 MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL 3CZD,3UNW,3UO9,3VOY,3VOZ,3VP0,3VP1,3VP2,3VP3,3VP4,5FI2,5FI6,5FI7,5HL1,6LOX,6UL9,6UMD,7REN,7RGG,8BSK,8BSL,8BSM,8BSN,8GWR Glutaminase kidney isoform, mitochondrial GLSK_HUMAN O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40 835149 COC(C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2cccnn2)s1)c1cc(OC)cc(OC)c1 InChI=1S/C21H25N7O4S/c1-30-15-9-13(10-16(11-15)31-2)18(32-3)19(29)24-21-27-26-20(33-21)23-14-6-8-28(12-14)17-5-4-7-22-25-17/h4-5,7,9-11,14,18H,6,8,12H2,1-3H3,(H,23,26)(H,24,27,29)/t14-,18?/m1/s1 MCWGAWNVXRUZFM-IKJXHCRLSA-N 416690 2-(3,5-dimethoxyphenyl)-2-methoxy-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide::US10323028, Example 23::US10323028, Example 43::US10323028, Example 44 Glutaminase kidney isoform, mitochondrial Homo sapiens 20.0 US Patent 10.7270/Q20R9RTG aid1803901 US10323028 Nissink, JW; Finlay, MR; Charles, MD 6/18/2019 8/24/2020 AstraZeneca AB http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416690 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5879&target=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416690&enzyme=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search 154584195 433916615 1 MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL 3CZD,3UNW,3UO9,3VOY,3VOZ,3VP0,3VP1,3VP2,3VP3,3VP4,5FI2,5FI6,5FI7,5HL1,6LOX,6UL9,6UMD,7REN,7RGG,8BSK,8BSL,8BSM,8BSN,8GWR Glutaminase kidney isoform, mitochondrial GLSK_HUMAN O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40 835150 COC(C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2cccnn2)s1)c1cc(OC)cc(OC)c1 InChI=1S/C21H25N7O4S/c1-30-15-9-13(10-16(11-15)31-2)18(32-3)19(29)24-21-27-26-20(33-21)23-14-6-8-28(12-14)17-5-4-7-22-25-17/h4-5,7,9-11,14,18H,6,8,12H2,1-3H3,(H,23,26)(H,24,27,29)/t14-,18?/m1/s1 MCWGAWNVXRUZFM-IKJXHCRLSA-N 416690 2-(3,5-dimethoxyphenyl)-2-methoxy-N-[5-[[(3R)-1-pyridazin-3-ylpyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]acetamide::US10323028, Example 23::US10323028, Example 43::US10323028, Example 44 Glutaminase kidney isoform, mitochondrial Homo sapiens 48.2 US Patent 10.7270/Q20R9RTG aid1803901 US10323028 Nissink, JW; Finlay, MR; Charles, MD 6/18/2019 8/24/2020 AstraZeneca AB http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416690 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5879&target=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416690&enzyme=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search 154584195 433916615 1 MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL 3CZD,3UNW,3UO9,3VOY,3VOZ,3VP0,3VP1,3VP2,3VP3,3VP4,5FI2,5FI6,5FI7,5HL1,6LOX,6UL9,6UMD,7REN,7RGG,8BSK,8BSL,8BSM,8BSN,8GWR Glutaminase kidney isoform, mitochondrial GLSK_HUMAN O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40 835151 COC[C@H](C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2ccc(C)nn2)s1)c1ccccc1 InChI=1S/C21H25N7O2S/c1-14-8-9-18(25-24-14)28-11-10-16(12-28)22-20-26-27-21(31-20)23-19(29)17(13-30-2)15-6-4-3-5-7-15/h3-9,16-17H,10-13H2,1-2H3,(H,22,26)(H,23,27,29)/t16-,17+/m1/s1 JLQVBCYPFNMOEH-SJORKVTESA-N 416712 (2S)-3-Methoxy-N-[5-[[(3R)-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]-2-phenyl-propanamide and (2R)-3-Methoxy-N-[5-[[(3R)-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]-2-phenyl-propanamide::US10323028, Example 45(a)::US10981904, Example 45(a) Glutaminase kidney isoform, mitochondrial Homo sapiens 1600 US Patent 10.7270/Q20R9RTG aid1803901 US10323028 Nissink, JW; Finlay, MR; Charles, MD 6/18/2019 8/24/2020 AstraZeneca AB http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416712 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5879&target=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416712&enzyme=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search 129161426 433916626 1 MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL 3CZD,3UNW,3UO9,3VOY,3VOZ,3VP0,3VP1,3VP2,3VP3,3VP4,5FI2,5FI6,5FI7,5HL1,6LOX,6UL9,6UMD,7REN,7RGG,8BSK,8BSL,8BSM,8BSN,8GWR Glutaminase kidney isoform, mitochondrial GLSK_HUMAN O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40 835152 COC[C@@H](C(=O)Nc1nnc(N[C@@H]2CCN(C2)c2ccc(C)nn2)s1)c1ccccc1 InChI=1S/C21H25N7O2S/c1-14-8-9-18(25-24-14)28-11-10-16(12-28)22-20-26-27-21(31-20)23-19(29)17(13-30-2)15-6-4-3-5-7-15/h3-9,16-17H,10-13H2,1-2H3,(H,22,26)(H,23,27,29)/t16-,17-/m1/s1 JLQVBCYPFNMOEH-IAGOWNOFSA-N 416713 (2R)-3-Methoxy-N-[5-[[(3R)-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]-2-phenyl-propanamide and (2R)-3-Methoxy-N-[5-[[(3R)-1-(6-methylpyridazin-3-yl)pyrrolidin-3-yl]amino]-1,3,4-thiadiazol-2-yl]-2-phenyl-propanamide::US10323028, Example 45(b)::US10981904, Example 45(b) Glutaminase kidney isoform, mitochondrial Homo sapiens 146 US Patent 10.7270/Q20R9RTG aid1803901 US10323028 Nissink, JW; Finlay, MR; Charles, MD 6/18/2019 8/24/2020 AstraZeneca AB http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=416713 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5879&target=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=416713&enzyme=Glutaminase+kidney+isoform%2C+mitochondrial&column=ki&startPg=0&Increment=50&submit=Search 129161483 433916627 1 MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL 3CZD,3UNW,3UO9,3VOY,3VOZ,3VP0,3VP1,3VP2,3VP3,3VP4,5FI2,5FI6,5FI7,5HL1,6LOX,6UL9,6UMD,7REN,7RGG,8BSK,8BSL,8BSM,8BSN,8GWR Glutaminase kidney isoform, mitochondrial GLSK_HUMAN O94925 Q9UL05 Q9UL06 Q9UL07 Q9UN40